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ABSTRACT 
 
 
Background 
The irrational use of medicines, and increasingly antimicrobials, remains a key health problem in 
many developing countries including Zambia. Inappropriate, ineffective and inefficient use of 
medicines is common in health facilities at all levels. There are many factors influencing irrational 
prescribing and dispensing of antimicrobials including patients, prescribers, dispensers, the supply 
system (including industry influences), government regulations and medicines information and 
misinformation. 
 
Study aim 
The aim of the study was to assess the rational use and availability of antimicrobials at primary level 
health facilities under the Lusaka district community health office, Zambia.  
 
Study design 
The study was a cross-sectional descriptive study, with prospective and retrospective components. A 
standardized research methodology, including tools and indicators, adapted from the World Health 
Organization, was employed.  
 
Study population and sampling 
The study population included all the 30 government primary level health facilities (health centres) in 
Lusaka District, from which 20 primary health facilities were sampled using a combination of 
purposive and random sampling. Using the WHO standard indicators of rational drug use, this study 
assessed 800 patient encounters, 520 medicines inventory records, and other baseline data, from 20 
health facilities at three different levels under the Lusaka district community health office, Zambia.  
 
Data collection 
The data collection tools were numbered and labeled. Tool 1: Prescribing Indicator Form was used to 
collect prescribing data; Tool 2: Patient Care (Pharmacy) Form was used to record dispensing data; 
Tool 3: Antimicrobial Availability Form for recording data for the availability of the key indicator 
antimicrobials and their substitutes; Tool 4: Facility Indicator Consolidation Reporting Form  was 
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used for consolidating the data collected for each health facility under study; and Tool 5: Facility 
Medicines Use Indicator Consolidation Form was used for the consolidation of the drug use data for 
the entire study. Third year Pharmacy Technology students were trained for the data collection 
process. The patients were first observed from outside the prescriber’s room and the dispensing area 
for consultation and dispensing times respectively, and then they were interviewed to collect the 
prescribing and dispensing data. The tools were pre-tested.  
Data analysis 
After data checking and consolidation, quantitative data were categorized into continuous numerical 
variables. Calculations were done manually and using computerized analysis (Epi Info package) and 
presented as simple frequency and means.  
 
Ethics 
Ethical clearance for the study was obtained from University of the Western Cape Senate Research 
Committee. Permission was obtained from the Lusaka Provincial and District health offices, being the 
authorities that are overseeing the health facilities included in the study. Furthermore, permission was 
obtained from the health centre in-charges. Consent was obtained from healthcare providers and 
patients.  
 
Key results and discussion  
The study found that at the primary level facilities there were more Clinical Officers (55%) than 
Medical Doctors (25%) and Registered Nurses (20%) in charge of prescribing. The main dispensers 
were Pharmacy Technologists (85%); there were no Pharmacists available in any of the facilities. A 
third [259 (32.4 %)] of all the 800 patients in the study were children below 12 years of age. Across the 
clinics, a mean of 2.94 medicines were prescribed per prescription, with an extremely low rate of 
prescribing drugs by generic name (36.7%). The proportion of prescriptions including an antibiotic 
was 36.2 % and 3.4 % included an injectable drug. Linking the antimicrobials and injections to 
patient diagnoses indicated that many were probably irrational, prescribing decisions. Amoxicillin 
and metronidazole were by far the most commonly prescribed antimicrobials at 32.0 % and 17.2 % of 
total antimicrobials, respectively. The essential drugs list was available in 80.0% of facilities and a 
high percentage of medicines were prescribed from the essential medicines list (81.2%). The overall 
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mean percentage of medicines packages correctly labeled was considerably low at 44.8 %. The 
average consultation time was short at 4.0 (range 1-8.4) minutes, whereas the dispensing times were 
equally short and averaged at 116.6 (range 15-360) seconds, with the range of 15 to 360 seconds. The 
average percentage of first line antimicrobials available at health facilities was 79 %; and the average 
percentage of second line, substitute, antimicrobials available was 15 %.  
 
Conclusion 
In line with studies from other settings, this medicines use study found considerable overuse and 
irrational use of antimicrobials in the primary health care clinics in Lusaka District. Irrational 
medicine prescribing was common and poor dispensing practices were also seen, resulting in poor use 
of and adherence to medicines and, consequently, poor therapeutic outcomes.  
 
Recommendations 
Several recommendations have been formulated. They include: Reinforcing the Drug Therapeutic 
Committees (DTCs) at the national and the local facility level to help manage medicines use; 
clarification of prescribers and dispensers roles and responsibilities; development, enforcement or 
adaption of standard operating procedures (SOPS) for prescribing and dispensing;  and improvement 
of prescribing and dispensing practices through introduction of appropriate education, supervision 
and audit. 
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CHAPTER 1: INTRODUCTION 
 
1.1. Introduction  
 
Antimicrobial agents are medicines that kill micro-organisms such as fungi, bacteria and viruses, or 
inhibit their growth (Katzung et al., 2012). Antimicrobial agents have been at the forefront of the 
battle to reduce the consequences of infectious diseases for much of the past century. Their use has 
reduced the prevalence and mortality associated with classical infectious diseases. The development 
of antimicrobial drugs represents one of the most important advances in therapeutics, both in the 
control and cure of serious infections and in the prevention and treatment of infectious complications 
of other therapeutic modalities. Antimicrobial medicines are grouped according to the 
microorganisms they act primarily against and include antibacterials (beta lactam antibacterials, 
erythromycin), antifungals (azole creams), antiprotozoal agents (antimalarials, metronidazole, 
nilazoxanide), and antihelminthics (mebendazole). Antimicrobials are also present in dermatological 
and opthalmological preparations such as silver sulfadiazine cream for burns, and tetracycline eye 
ointment respectively (Katzung et al., 2012).  
 
Rational medicine use refers to the prescribing of the right medicine for the right indication in the 
right dosage and dosing frequency for the correct duration (WHO, 1987). According to Starrels et al. 
(2009) irrational (inappropriate) use of antimicrobials can mean either of two things: the use of 
antimicrobials when no health benefit is possible, such as to treat upper respiratory tract infections 
caused by viruses; or the suboptimal use of antimicrobials for responsive conditions, such as the 
choice of drugs with an unnecessarily broad spectrum, an incorrect dosage or duration, or poor patient 
adherence to the prescribed treatment. When available, medicines, including antimicrobials, are often 
used incorrectly; it is estimated that globally around 50% of all medicines are prescribed, dispensed 
or sold inappropriately, while 50% of patients fail to take their medicines appropriately (WHO, 
2002). Cizman (2003) estimated that 20 to 50 percent of total antibiotic use is inappropriate.  
 
Misuse of antimicrobials in humans is prevalent in both low- and high-income countries. There is 
evidence, for example, that there is a very serious antimicrobial overuse of antimicrobials for viral 
upper respiratory tract infections whilst there is underuse of appropriate antimicrobials for 
pneumonia. There is also serious overuse of antimicrobials in acute cases of diarrhea, but underuse of 
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oral rehydration solution (Springmann, 2015 in World Bank Group, 2016). As documented in 
different studies reviewed by Colson et al. (2015, in World Bank Group, 2016), there is an excessive 
number of antimicrobials in the pharmaceutical market and aggressive pharmaceutical promotion and 
economic incentives, whereby prescribers gain income from dispensing or selling the medicines they 
prescribe. There is also poor availability of independent medicine information such as clinical 
guidelines and drug bulletins, and an apparent poor adherence to infection prevention control 
protocols in health facilities. Over or irrational prescribing, serious antimicrobial misuse in primary 
health care facilities and hospitals, and treatment withdrawal by patients is widely seen. All these are 
among key factors contributing to the growing antimicrobial resistance (World Bank Group, 2016). 
Antimicrobial resistance occurs when microorganisms such as bacteria, fungi, viruses, and parasites 
change when they are exposed to antimicrobial medicines such as antimicrobials, antifungals, 
antivirals, antimalarials, and anthelmintics. Microorganisms that develop antimicrobial resistance are 
sometimes referred to as "superbugs", and as a result, the medicines become ineffective and 
infections persist in the body, increasing the risk of spread to others (WHO, 2012).  
 
Drug-resistant infections, in both humans and animals, are on the rise globally. If the spread of 
antimicrobial resistance (AMR) is unchecked, many infectious diseases will again be untreatable, 
reversing a century of progress in public health (World Bank Group, 2016). AMR threatens the 
effective prevention and treatment of an ever-increasing range of infections caused by bacteria, 
parasites, viruses and fungi. It is a complex problem that affects all of society and is driven by many 
interconnected factors. Therefore, being an increasingly serious threat to global public health AMR 
requires action across all government sectors and society. Furthermore, the cost of health care for 
patients with resistant infections is higher than care for patients with non-resistant infections due to 
longer duration of illness, additional tests and use of more expensive drugs. New research from the 
World Bank Group (2016) shows that AMR would increase poverty, and affect the poorest countries, 
like Zambia, the most. According to a new report by the World Bank Group entitled "Drug Resistant 
Infections: A Threat to Our Economic Future" (2016), drug-resistant infections have the potential to 
cause a level of economic damage similar to-and likely worse than-that caused by the 2008 financial 
crisis. The research shows that a high-case scenario of antimicrobial resistance (AMR), where 
antimicrobials and other antimicrobial medicines no longer treat infections the way they are supposed 
to, could cause low-income countries to lose more than 5% of their GDP and push up to 28 million 
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people, mostly in developing countries, into poverty by 2050. Currently, the world is broadly on track 
to eliminate extreme poverty by 2030, reaching close to the target of less than 3% of people living in 
extreme poverty. AMR risks putting this target out of reach. Low-income countries would lose more 
every year leading up to 2050, with the loss exceeding 5% of GDP in 2050 in the latter scenario. And, 
unlike the financial crisis of 2008, there would be no prospects for a cyclical recovery in the medium 
term, as the costly impact of AMR would persist (World Bank Group, 2016). 
 
New resistance mechanisms are emerging and spreading globally, threatening our ability to treat 
common infectious diseases, resulting in prolonged illness, disability, and death. Without effective 
antimicrobials for prevention and treatment of infections, medical procedures such as organ 
transplantation, cancer chemotherapy, diabetes management and major surgeries such as, caesarean 
sections or hip replacements, become very high risk. AMR increases the cost of health care with 
lengthier stays in hospitals and more intensive care required. It is a global concern which is putting 
the gains of the Millennium Development Goals (MDGs) at risk and further endangers achievement 
of the Sustainable Development Goals (SDGs). For instance, globally, 480 000 people develop multi-
drug resistant TB each year, and drug resistance is starting to complicate the fight against HIV and 
malaria, as well. WHO estimates that, in 2014, there were about 480 000 new cases of multidrug-
resistant tuberculosis (MDR-TB), a form of tuberculosis that is resistant to the 2 most powerful anti-
TB drugs. Only about a quarter of these (123 000 cases) were detected and reported. Globally, only 
half of MDR-TB patients were successfully treated in 2014 (WHO, 2012).  
 
As of July 2016, resistance to the first-line treatment for P. falciparum malaria (artemisinin-based 
combination therapies, also known as ACTs) has been confirmed in five countries of the Greater 
Mekong sub-region (Cambodia, the Lao People's Democratic Republic, Myanmar, Thailand and 
Vietnam). However, along the Cambodia-Thailand border, P. falciparum has become resistant to 
almost all available antimalarial medicines, making treatment more challenging and requiring close 
monitoring. There is a real risk that multidrug resistance will soon emerge in other parts of the sub-
region as well. The spread of resistant strains to other parts of the world could pose a major public 
health challenge and jeopardize important recent gains in malaria control. Antiviral drugs are 
important for treatment of epidemic and pandemic influenza. So far, virtually all influenza A viruses 
circulating in humans are resistant to one category of antiviral drugs  such as amantadine and 
 
 
 
 
4 
 
rimantadine, however, the frequency of resistance to the neuraminidase inhibitor oseltamivir remains 
low (1-2%). Antiviral susceptibility is constantly monitored through the WHO Global Influenza 
Surveillance and Response System (World Bank Group, 2016).  
 
There have been concerns about the rational ‘essential’ antimicrobial use and resistance since the first 
widespread use of antimicrobials in humans, and more recently in veterinary use. These concerns 
have been raised at different levels of healthcare, and social-economic national levels. For instance, 
most developing countries, including Zambia are rocked with problems such as shortage of diagnostic 
tools for communicable diseases as well as availability of these antimicrobials; and in certain cases 
lack of the appropriately designated prescribers of these antimicrobials (Republic of Zambia Ministry 
of Health, 2011). This concern has grown and become the focus of clinical, scientific, and political 
activity. In part, the political interest is a consequence of publicizing a bleak picture of a post-
antibiotic world, whereby in a near future, all or most antimicrobials lose their efficacy due to 
resistance. There are, however, dangers in using a discourse of fear, rather than providing evidence of 
the use of antimicrobials in order to create appropriate direction, and intervention wherever deemed 
necessary. Many governments now use a risk assessment approach to identify security concerns, 
based on reasonable worst-case scenarios (Thapar & Sanderson, 2004).  
 
Unfortunately, patients often receive antimicrobials inappropriate to their clinical needs, in doses that 
do not meet their own individual requirements, for an inadequate period of time, and usually at the 
unnecessary cost to them and their community (Fawler, Walker & Davies, 2014). This irrational use 
of the antimicrobial agents has led to the development of resistance by the respective micro-
organisms, which has been further exacerbated by the poor or none availability of the antimicrobials. 
Therefore, the rising tide of antibacterial resistance and the lack of a diverse, vibrant pipeline of novel 
antibacterial agents is a global crisis that impairs our ability to treat life-threatening infections 
(Thapar & Sanderson, 2004).  
 
There is no doubt that for effective policy-based action to occur, antimicrobial resistance needs to be 
seen as a national and international security priority, particularly as the major cost of inaction will 
mostly be felt in the future. Most importantly, presenting the evidence in a manner that is used to 
encourage prioritization of security policy is not only justified, but also essential to drive action in 
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this area. Therefore, this study investigates the rational use and availability of antimicrobials at 
primary level health facilities under the Lusaka district community health office, Zambia. 
 
 
1.2. Setting  
 
Zambia is a landlocked Sub-Saharan country, which covers a land area of 752,612 square kilometers. 
Zambia has a total of ten provinces with Lusaka Province, which hosts the capital city of Zambia, 
having a total estimated population of about 2, 303, 045 - approximately 17 % of the country’s 
population. Lusaka Province has eight administrative districts, including Lusaka District, the capital 
city of Zambia which covers an area of over 70km
2
, about 80% of the Lusaka Provincial population 
(1, 828, 385, in 2011) and one hundred and ninety-four (66.0%) of the 294 provincial health facilities 
(Republic of Zambia Ministry of Health, 2011). The 149 private health facilities, which account for 
about 75 % of the health facilities in Lusaka District, include 5 first level hospitals and 144 urban 
health centers (three of which are owned by non-governmental (faith based) organizations), and they 
serve the entire district catchment population. The 45 public sector health facilities in Lusaka District 
consist of 30 urban health centers, seven health posts, three third level hospitals, one second level 
hospital and four first level hospitals (total 45), accounting for 25 % of the health facilities in the 
district (Republic of Zambia Ministry of Health, 2012). 
 
The primary health facilities under the Lusaka District Community Health Office have been 
designated into eight zones for administrative purposes and the primary health facilities have been 
further distinguished and grouped according to their sizes (large, medium or small). The sizing of the 
primary health facilities is based on the range of services offered and the respective catchment 
populations. For the large facilities, these services include HIV Counseling and Testing (HCT), 
Prevention of Mother to Child Transmission of HIV (PMTCT), Male Circumcision (MC), emergency 
obstetric care (EMOC), TB diagnosis, dental services and delivery services. All the eight large health 
centers offer all the aforementioned services, with five out of the eight offering X-ray services, and 
one of the eight has an operating theatre, and another has a CD4 machine. The total catchment area 
for the thirty health centres and the nine health posts in Lusaka district is 2, 115, 596, which translates 
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to 92 % of the entire Lusaka provincial population-see the sampling frame in Appendix 4 (Republic 
of Zambia Ministry of Health, 2011).  
 
Zambia faces three main health resources problems; namely the absolute shortages of health workers, 
inequities in the distribution of health workers and skills-mix, which all favor urban areas. In the 
urban areas, the better qualified health workers are assigned to secondary or tertiary health facilities 
as opposed to the primary health facilities (Republic of Zambia Ministry of Health, 2011). Currently, 
the eight large health centers have at least a doctor and a clinical officer as prescribers, and a 
pharmacist and a pharmacy technologist as dispensers. The medium and small health centers have at 
least a clinical officer and a pharmacy technologist, with a doctor either on the health centre staff or 
just making rounds, or having special clinics (Republic of Zambia Ministry of Health, 2011) 
 
1.3. Problem statement 
 
In developing countries like Zambia, the burden of infectious diseases is relatively high. However, 
the capacity for disease treatment, and the awareness of antimicrobial resistance are not well 
established at the primary level of the Zambian health system, and as a result the ability to avert their 
consequences is significantly compromised (Republic of Zambia Ministry of Health, 2011). In 
addition, although government (or private sector) primary level health facilities are the first point of 
contact in the country’s health system and, in certain areas of the country, the only health providers, 
there are times when these facilities are not able to provide patients with all the medicines they 
require for treating infectious diseases (Republic of Zambia Ministry of Health, 2011). This was 
demonstrated first-hand during my prior experience as a community pharmacist, working in a private 
pharmacy in two community medical districts, where I often received prescriptions for patients to 
purchase medicines, including antimicrobials, due to non-availability at government primary health 
facilities. However, despite the importance of antimicrobials, little is known about the rational use 
and availability of these medicines at the primary level health facilities in Zambia. This study seeks to 
assess the rational use and availability of antimicrobials at primary level of health facilities in an 
urban district in Zambia. It is hoped that the information generated will provide a platform for future 
interventions to improve rational use and availability of antimicrobials in this setting. 
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CHAPTER 2: LITERATURE REVIEW 
 
2.1. Introduction  
This section discusses the available literature on the use, prescribing and dispensing of antimicrobials, 
the availability of antimicrobials, and the availability and access to the essential medicines at relevant 
health care settings. 
2.2. Increasing consumption of antimicrobials 
 
New estimates of global antimicrobial use that include low and middle income countries (LMICs) 
have recently been published, combining direct sales data from manufacturers and indirect sales data 
from wholesalers to estimate the total volume of antimicrobials sold in hospital and retail pharmacies 
for 71 countries from 2000 to 2010 (Van Boeckel et al. 2015). It is estimated that between 2000 and 
2010, the total global antibiotic consumption grew by more than 30%, from approximately 50 billion 
to 70 billion standard units (SU). Penicillins and cephalosporins accounted for nearly 60 % of total 
consumption in 2010, increasing by 41% from 2000. Among the oldest antimicrobials on the market, 
these are still the most common first-line antimicrobials and the primary treatment for common 
infections around the world (Van Boeckel et al. 2015). Worldwide, increases were also significant for 
two “last-resort” antibiotic classes: carbapenems (approximately 40%) and polymixins (13%) (Van 
Boeckel et al. 2015). The growth in retail carbapenem sales was particularly steep in India, Pakistan, 
and Egypt – in these countries it is likely that some drugs prescribed in hospitals may be dispensed at 
retail pharmacies. 
 
The countries consuming the most antimicrobials overall in 2010 were India, 13 billion SU; China, 10 
billion SU; and the United States, 7 billion SU. However, in per capita terms, among these countries, 
the United States led in 2010 with 22 SU per person, compared with 11 SU in India and 7 SU in 
China (Van Boeckel et al. 2015), representing an overall decline of 5 percent in per capita prescribing 
since 1999. Annual outpatient prescription rates in the United States are lower than in many Southern 
European nations but higher than in Scandinavia and the Netherlands (CDDEP, 2015). Most high-
income countries maintained or decreased their antibiotic consumption from 2000 to 2010. The five 
rapidly growing countries known as the BRICS had the greatest upsurge in antibiotic use from 2000 
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to 2010: 68% in Brazil, 19% in Russia, 66% in India, 37% in China, and 219% in South Africa. 
About three-quarters of the total increase in global consumption occurred in these nations; however, 
they accounted for only one-third of the world’s increase in population from 2000 to 2010 (Van 
Boeckel et al. 2015). 
 
Even with the substantial increase in overall use, per capita consumption is still lower in the BRICS 
countries than in the United States. In 2010, in the United States, penicillins were the most commonly 
prescribed antimicrobials (38%), followed by cephalosporins (16%), tetracyclines (15%), macrolides 
(12%) quinolones (9%), and trimethoprim (10%) (Van Boeckel et al., 2015). The wide range of 
consumption values and different patterns of change suggest that antibiotic consumption is driven not 
strictly by disease incidence. In the United States, for example, antibiotic prescribing rates are related 
to physician density (Van Boeckel et al., 2015). 
 
The World Health Organization (WHO) (2006) has created a database of studies on the use of 
medicines in primary care (generally for acute conditions) in developing and transitional countries. 
The database consists of systematically extracted quantitative information on medicines use measured 
in these studies, plus details on study setting and methodology extracted from articles and reports 
published or produced during the period 1990–2006. Six hundred and seventy-nine (679) studies 
from 97 countries were identified, 71% had been undertaken in the public sector, 26% in the private-
for-profit sector and 3% in the private-not-for profit sector. According to this evidence, the use of 
antimicrobials has remained sub-optimal in all regions of the world over the last 20 years, that it 
appears not to be improving, and that it is worse in the private sector as compared to the public sector. 
Furthermore, according to WHO (2006), while the use of generic and essential medicines may have 
increased slightly over the past 20 years, overall use of medicines has increased and compliance with 
guidelines has still remained low. 
 
Evidence is overwhelming that antimicrobial agents are vastly overprescribed in outpatient settings in 
the developed countries, and the availability of antimicrobial agents without prescription in many 
developing countries has already severely limited therapeutic options in the treatment of life-
threatening infections by facilitating the development of antimicrobial resistance. Antibacterial 
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resistance–associated infections are known to increase morbidity, mortality, and cost of treatment, 
and to potentially put others in the community at higher risk of infections (WHO, 1993).  
 
Between 2000 and 2010, total global antimicrobial consumption grew by more than 30 percent, from 
approximately 50 billion to 70 billion standard units, based on data from 71 countries, including most 
high population countries (Van Boeckel et al., 2015). Van Boeckel et al. (2015) further asserted that 
per capita consumption is generally higher in high-income countries, but the greatest increase in 
antibiotic use between 2000 and 2010 was in LMICs, where use continues to rise.  
 
2.3. Use of Antimicrobials-measured using WHO RMU indicators 
 
Overuse and misuse of antimicrobial agents is a particularly serious global problem. Established and 
newly emerging infectious diseases are increasingly threatening the health of populations. If 
antimicrobials become ineffective, these diseases will lead to increased morbidity, health-care use and 
eventually premature mortality (Levy, 2005). Furthermore, antimicrobials are required for other 
treatments (taken for granted in developed countries), such as surgery and cancer chemotherapy, 
which would become unavailable with the disappearance of effective antimicrobials. Unfortunately, 
while resistance to older antimicrobials is increasing, the development of new generations of 
antimicrobial medicines is stalling (Kaplan & Laing, 2004). Therefore, efficient use of existing 
antimicrobials is needed to ensure the availability in the long term of effective treatment of bacterial 
infections. Efficient use includes both restrictive and appropriate use, with inappropriate and incorrect 
use of antimicrobials occurring in both developing and developed countries. Two thirds of all 
antimicrobials are sold without prescription, through unregulated private sectors. Even in those 
European countries where over-the-counter delivery of antimicrobials is not allowed, patients use 
antimicrobials without prescription (Grigoryan, 2007). Low adherence levels by patients are 
common, many patients taking antimicrobials in under-dose or for shortened duration, for example, 
three instead of five days (Kariuri & Dougan, 2014; Lansang et al., 1990). 
 
Likewise, in the developed countries there is much evidence of irrational use of medicines. While 
much intervention research has been undertaken and effective interventions identified for improving 
the use of medicines, few of these interventions have been scaled up to national level. Furthermore, 
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about half of all countries are not implementing many basic policies recommended by WHO to 
promote rational use of medicines. Many health system factors and stakeholders influence the use of 
medicines and due to these complex underlying factors, it has been recommended that countries 
develop a coordinated national approach to promoting rational use of medicines and containing 
antimicrobial resistance (ICIUM 2004, WHO 2001). WHO Member States endorsed such a 
coordinated approach in adopting Resolutions WHA 58.27 in 2005 and WHA60.16 in 2007 (World 
Health Assembly Resolution, 2005 & 2007). 
 
The Alliance for the Prudent Use of Antimicrobials (APUA) (2011) demonstrated that the highest 
antibiotic use in Zambia, by age, is between 0 and 5 years, followed by 21 to 35 years. Among the 
antibacterials investigated were ciprofloxacin tablets, cotrimoxazole tablets and syrup, amoxicillin 
tablets/capsules/syrup and other penicillins and erythromycin syrup. APUA (2011) found that in 
Zambia, laboratory capacity is generally poor and patchy; that malaria is driving antibiotic use, 
whereby nearly 20% of antimicrobials are prescribed for malaria in adults; and that amoxicillin is 
highly used, but not for those who need it most. However, this research was focusing on the private 
sector pharmacies. 
 
Seasonal patterns 
Antibiotic use is also correlated with the spread of seasonal infections, such as influenza (Polgreen et 
al. 2011). From 2000 to 2010, antibiotic use peaked in North America and Western Europe from 
December through February, in South America in June and July, and in most of the tropics from 
August through September (Sun et al. 2012). These patterns are consistent with a higher incidence of 
infectious disease during winter flu season and vector borne febrile diseases during heavy rains and 
monsoons (Van Boeckel et al. 2015). Gram-negative bloodstream infections are more prevalent in 
hotter weather: independent of season, humidity, and precipitation an increase of 10 degrees 
Fahrenheit (5.6°C) in monthly temperature increased the frequency of Gram-negative bacterial 
infections. 
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2.3.1. Prescribing and dispensing of antimicrobials 
 
Despite the global problem of inappropriate use, few countries are monitoring medicines use or 
taking sufficient action to correct the situation (WHO, 2006). Currently, there is a substantial global 
evidence for continuing irrational use of medicines. Less than 40% of patients in the public sector and 
less than 30% in the private sector are treated in accordance with existing guidelines, and the situation 
is not improving in either developing or transitional countries. For instance, less than 60% of children 
with acute diarrhoea receive necessary oral rehydration therapy yet more than 40% receive 
unnecessary antimicrobials; only 50% of people with malaria receive the recommended first-line 
antimalarial; only 50–70% of people with pneumonia are treated with appropriate antimicrobials, yet 
up to 60% of people with viral upper respiratory tract infection receive antimicrobials inappropriately 
(WHO, 2011). Irrational use may take many different forms, for example, polypharmacy, over-use of 
antimicrobials and injections, failure to prescribe in accordance with clinical guidelines and 
inappropriate self-medication. Doctors prescribe antimicrobials to patients who do not need them, 
while patients do not adhere to their treatment causing the risk of antimicrobial resistance (Pechère et 
al., 2007). 
 
Sunil, Punam and Madhuri (2005) analyzed the patterns of prescriptions and drug dispensing using 
World Health Organization core medicine use indicators and some additional indices in the pediatric 
department of the Lokmanya Tilak Municipal Medical General Hospital in India. Data were collected 
prospectively by scrutinizing the prescriptions written by pediatric resident doctors and by 
interviewing parents of 500 outpatient children. They found that the average number of medicines per 
encounter was 2.9 and 73.4% drugs were prescribed by generic name. Majority of medicines 
prescribed were in the form of syrups (60.8%). Use of antimicrobials (39.6% of encounters) was 
frequent, but injection use (0.2% of encounters) was very low. A high number of medicines 
prescribed (90.3%) conformed to a model list of essential medicines and were dispensed (76.9%) by 
the hospital pharmacy. Certain drugs (5.7%) prescribed as syrups were not dispensed, although they 
were available in tablet form. Most parents (80.8%) knew the correct dosages, but only 18.5% of 
drugs were adequately labeled. No copy of an essential drugs list was available. The availability of 
key drugs was 85%. They concluded that interventions to rectify over prescription of antimicrobials 
and syrup formulations, inadequate labeling of medicines and lack of access to an essential medicines 
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list were necessary to further improve rational drug use in our facility. Interventions were also 
necessary to improve education and counseling activities to patients. At least some of this poor 
knowledge could be linked to the lack of consultation and dispensing times spent by prescribers and 
dispensers at these health facilities; proper pharmacy labels could contribute to better compliance and 
improved patient understanding of their medications.  
 
An appropriate diagnosis is an important component in the rational drug therapy. For correct 
diagnosis, clinicians should spend more time in evaluating the signs, symptoms and laboratory 
investigations. It is safely assumed that the more the consultation time, the better the chances of 
getting a right diagnosis. The WHO (2012) recommends that patient consultation time should be at 
least 15 minutes whereas the pharmacist (medicine dispenser) should spend at least 180 seconds (3 
minutes) in orienting each patient on the use of the prescribed medicines. However, any drug 
utilization study based on the WHO core drug use indicators has limitations. Determining the quality 
of diagnosis and evaluating the adequacy of drug choices is beyond the scope of the prescribing 
indicators. Also, the patient care indicators do not capture many fundamental issues related to the 
quality of examination and treatment. 
 
Bhartiy, et al., (2008) conducted a cross-sectional survey in 26 Primary Health Care facilities of 
Madhya Pradesh State in India to find out the current status of the ‘prescribing practices’ at these 
facilities. Overall, the average number of medicines prescribed per prescription was 2.8; most 
commonly prescribed drugs were NSAIDs, antimicrobials, multivitamins and antihistamines. Drugs 
prescribed by generic name were 48.5%; prescription with antimicrobials and injections were 60.9% 
and 13.6% respectively; and drugs prescribed from EML were 66.9%. They concluded that 
prescribing practices of the Madhya Pradesh were irrational, and included polypharmacy, overuse of 
antimicrobials and injections, lesser numbers written in generic names and prescribed from EML. 
There was an urgent need for some interventions to improve the situation. 
 
Odusanya (2004) measured drug-use indicators in a secondary health care facility in Lagos, Nigeria. 
Retrospective prescribing data was used and patient records were selected using a systematic 
sampling method. The average number of drugs per patient was 3.5, 14% of patients received at least 
one injection and 55% of patients were prescribed at least one antimicrobial. The injections were 
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prescribed for a variety of indications where oral therapy could have been used. Antimicrobials were 
prescribed largely for presumed infections. Odusanya (2004) concluded that the level of drug use at 
the hospital is sub-optimal and needed to be improved upon. 
 
Bashrahil (2010) used WHO standard indicators of rational drug use, in a study where he analyzed 
550 prescriptions from 20 health facilities at different levels throughout Hadramout governorate, in 
Yemen. A mean of 2.8 drugs were prescribed per prescription, with a low rate of prescribing drugs by 
generic name (39.2%). The proportion of prescriptions for antimicrobials was 66.2%, for injectable 
drugs 46.0% and for vitamins/tonics 23.6%. The essential medicines list was available in 78.9% of 
facilities and a high percentage of drugs were prescribed from the list (81.2%).  
 
2.3.2. What are the consequences of incorrect use of medicines? 
 
Incorrect use of medicines occurs in all countries, causing harm to people and wasting resources. 
Consequences may include antimicrobial resistance, adverse drug reactions and medication errors, 
lost resources, and eroded patient confidence. Overuse of antimicrobials increases antimicrobial 
resistance and the number of medicines that are no longer effective against infectious disease. Many 
surgical procedures and cancer therapies are not possible without antimicrobials to fight infection. 
Resistance prolongs illnesses and hospital stays, and can even cause death, leading to costs of US$ 4–
5 billion per year in the United States of America and €9 billion per year in Europe (Strategic Council 
on Resistance in Europe (SCORE), 2004). Harmful reactions to medicines caused by wrong use, or 
allergic reactions to medicines can lead to increased illness, suffering and death. Adverse drug 
reactions have been estimated to cost millions of dollars each year (Wiffen et al., 2002). Between 10–
40% of national health budgets are spent on medicines. Out-of-pocket purchases of medicines can 
cause severe financial hardship to individuals and their families. If medicines are not prescribed and 
used properly, billions of dollars of public and personal funds are wasted (WHO, 2012). Exacerbated 
by the overuse of limited medicines, drugs may be often out of stock or at unaffordable prices and as 
result erode patient confidence. Poor or negative health outcomes due to inappropriate use of 
medicines may also reduce the patient confidence (WHO, 2012). 
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2.4. Essential medicines concept and list 
 
The Zambian government, in an effort to ensure social justice, for economic reasons, belabors to 
ensure that the whole population has access to those antimicrobials that are absolutely vital to carry 
out the national health policy, with emphasis on primary health care in community health facilities 
(Republic of Zambia Ministry of Health, 2011). In order to further address the health problems, under 
its socioeconomic circumstances, and to improve medicine managerial capacities and use, the 
Zambian government, through its Ministry of Health, constituted an EML which contains all 
medicines prioritized for the prevailing communicable and non-communicable diseases. The essential 
medicines concept and the essential medicines list (EML) were first developed by the World Health 
Organization (WHO) in 1977 (WHO, 1993).  
 
In 1999, the Zambia Ministry of Health (MoH) developed and adopted a National Drug Policy 
(NDP), which is based on the requirements of the Basic Health Care Package (BHCP). A three year 
procurement plan for the period 2005 to 2007 was developed and the ‘Essential medicines list’ was 
also developed, intended to help in monitoring of stocks and management of procurements for critical 
drugs and supplies. Evidently, the EML has provided a rational basis not only for medicines 
procurement at the national level, but also for establishing medicine requirements and use at various 
levels within health care systems (WHO, 1992). Therefore, the EML is extremely vital in the 
promotion of the rational and efficient use of antimicrobial medicines. This is particularly important 
as according to the WHO (2009), studies from low income settings suggest high percentages of 
patients treated with antimicrobials or injections, many of which may be irrational. 
 
Over the past years, the bulk supply of essential medicines and medical supplies was erratic with 
more than 50% of essential medicines out of stock. However, the availability of Rural Health Centre 
Kits (RHCK) was fairly steady. On average, Health centre stocks improved from 73% in 2002 to 76% 
in 2004 (Zambia Pharmaceutical profile, 2009). The Republic of Zambia Ministry of Health (2011), 
in its National Health Strategic Plan (ZNHSP), 2011-2015, reported that during the period from 2006 
to 2008, the supply of essential medicines and medical supplies was erratic. However, during the last 
two years, 2009 and 2010, medicine availability improved to over 80%. During the same time, MoH 
ensured that the published Zambia standard treatment guidelines (STG) and the EML, which are 
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compiled in one book, was distributed to all Provincial Heath Offices for distribution. The emergence 
of new programs, limitations in human resources, weak supply chain management at certain levels, 
growing demand on services, and lack of appreciation of the logistics function as a core activity in 
health delivery system, negatively affected performance in this area. 
 
According to the Republic of Zambia Ministry of Health  (2013), the percentage of months for which 
essential medicines were in stock in the health centers in Chongwe, Kafue, Luangwa and Lusaka 
districts fluctuated from 83% in 2009 to 84% in 2010 and 76% in 2011. This leads to the issuing of 
prescriptions to patients to purchase medicines from the private sector at full price, much to the 
discontentment of the community. On the other hand, the percentage of months in which tracer drugs 
were available from 2009 to 2011, for the four districts was 100%. These drugs were; 
artemether/lumefantrine (coartem), paracetamol, cotrimoxazole, sulfadoxine/pyremethamine, 
amoxicillin and benzyl penicillin. However, not much has been indicated on the standards employed 
to select and determine the availability of these tracer drugs and it is therefore, not conclusive 
whether the sampled tracer medicines could be possibly representative of the essential medicines, let 
alone the antimicrobials. It is essential to note that drug use can be influenced by the availability of 
drugs, either the under-supply of essential medicines or the over-supply of non-essential 
pharmaceutical products.    
 
According to the Republic of Zambia Ministry of Health (2013), the percentage of months for which 
the key indicator essential medicines were in stock in health centers under Lusaka district was 
fluctuating from 85 % in 2009 to 90 % in 2010, and 95 % in 2011. Only 
sulphadoxine/pyremethamine, benzyl penicillin, amoxicillin, rifampicin/isoniazid and ketamine, were 
considered to be the key indicator essential medicines whose availability was used to generalize the 
availability of all other essential medicines (MOH, 2012). However, the WHO (1993) recommends 
the formulation of a list of key indicator essential medicines of at least 15 medicines, based on the 
provided model or the local disease burden. It is also worth noting that the availability of 
rifampicin/isoniazid could have confounded the results of the study considering that these anti-TB 
drugs are never out of stock, since HIV and TB programs are run selectively in Zambia, with separate 
funding for the programs and medicines. 
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2.4.1. Essential medicines and essential medicines list 
 
Essential medicines offer a cost-effective solution to many health problems in a developing country. 
They should be selected with due regard to disease prevalence, be affordable, with assured quality 
and be available in the appropriate dosage forms (Sunil, Punam & Madhuri, 2005). Prescribers can 
only treat patients in a rational way if they have access to an essential drugs list, essential drugs and 
clinical treatment guidelines are available on a regular basis (Hogerzeil, 2002) 
 
Clinical guidelines that give recommendations about appropriate health care aim to improve the 
quality of care. In Zambia currently, the EML has been compiled in the same volume as the standard 
treatment guidelines, demonstrating the close link between the two. A wide variety of treatment 
guidelines has been developed in the last decades for hospitals, clinics and physicians. For both acute 
and chronic communicable diseases, the implementation of guidelines is a complex process and the 
effects in terms of cost-effectiveness and long-term outcomes in patients are not well-studied 
(Francke et al., 2008). Research suggests that the implementation of guidelines is enhanced by higher 
quality of evidence supporting the recommendations, better compatibility of the recommendation 
with existing values; less complexity of the decision-making needed; more concrete description of the 
desired performance; and fewer new skills and organizational changes needed to follow the 
recommendations (Grol & Grimshaw, 2003). Also, the baseline level of adherence to recommended 
practice seems important: in a review on the effect of audit and feedback in improving professional 
practice, published in 2006, Jamtvedt et al. concluded that effects of these interventions are likely to 
be greater when baseline adherence is low. 
 
In 2004, Grimshaw et al. conducted a review to evaluate several implementation strategies. They 
concluded reminders, educational outreach, educational materials and audit and feedback showed 
modest effects.  On the other hand, multifaceted interventions did not appear to be more effective 
than single interventions and the effects of multifaceted interventions did not appear to increase with 
the number of interventions. However, other review studies in developed countries state that a 
combination of strategies to improve the implementation of guidelines is usually most effective 
(Francke, 2008). Differences in review findings may relate to whether the review focused on 
developed or developing countries. In developed countries a single intervention may be as effective 
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as multiple ones due to existing health infrastructure. In developing countries, like Zambia, multiple 
intervention packages often include building infrastructure, such as supervisory systems, which are 
likely to increase impact. 
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CHAPTER 3: METHODOLOGY 
 
3.1. Aim and objectives 
 
3.1.1. Aim   
The aim of this study was to assess the rational use and availability of antimicrobials at primary level 
health facilities under the Lusaka district community health office, Zambia.  
 
3.1.2. Objectives  
1. To describe the prescribing practices of antimicrobials by healthcare providers at 
primary level health facilities under the Lusaka district community health office, 
Zambia. 
2. To describe the dispensing practices of antimicrobials by healthcare providers at 
primary level health facilities under the Lusaka district community health office, 
Zambia. 
3. To determine the availability of antimicrobials at the primary level health 
facilities under the Lusaka district community health office, Zambia. 
4. To determine the availability and access to the essential medicines list at the 
primary level health facilities under the Lusaka district community health office, 
Zambia. 
 
3.2. Study design 
A cross-sectional descriptive study, with prospective and retrospective components, was used to 
assess the rational use and availability of antimicrobials at primary level health facilities in the 
Lusaka district community, Zambia. A standardized research methodology, including data collection 
tools (Appendix 1) and rational medicines use indicators (Appendix 2), was employed. This 
methodology was adapted from the World Health Organization (1993) publication: How to 
investigate drug use in health facilities. The patient care and prescribing indicators were measured 
prospectively by interviewing patients that will be seeing the medicines prescribers and dispensers on 
the data collection day. Availability of the essential antimicrobial medicines (or their substitutes) over 
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the past year (January to December, 2015) was determined retrospectively using records from the 
previous year. 
 
3.3. Study population 
 
The study population included all the 30 government primary level health facilities (health centers) in 
Lusaka District-and these made up the sampling frame (Appendix 3). Of these 30 primary level 
facilities, eight were classified as large health centers, five as medium health centers and 17 as small 
health centers. The primary level facilities will be the primary sampling unit. All patients (both adult 
and children) who received pharmaceutical and clinical services during the study period were 
included in the study. Emergency (trauma) patients, oral consultations, healthy children undergoing 
vaccination, healthy women attending for antenatal care or family planning, patients undergoing 
directly observed treatment (DOT) of tuberculosis, patients receiving antiretroviral therapy (ART) 
services, and the patients who came for refills of antiretroviral and/or any other medicines; were all 
excluded from the study. Immunizations were not counted as injections. 
 
3.4. Sampling 
 
WHO (1992) recommends that for a cross sectional study, at least 20 health facilities must be selected 
to represent a larger group of health facilities, and at least 30 patient encounters from each facility are 
recommended for this type of study. Sampling was carried out using a multi-stage technique 
involving two stages: the first stage involved selecting the health facilities and then the second stage 
involved selecting patients from the selected health facilities. 
 
i. Health facilities 
 
The primary sampling unit was the health centre. Twenty Lusaka District Community Health centres 
were sampled from a sampling frame of thirty health centres. Thirteen health facilities were 
purposefully sampled according to their sizes. This included eight large health centres - Chawama 
first level hospital-formally a clinic was counted as a large health facility, Chelstone clinic, Chilenje 
clinic, Chipata Clinic, Kalingalinga clinic, Kamwala clinic, Kanyama clinic, and Matero referral 
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clinic; and five medium health centres-Bauleni clinic, George clinic, Kabwata clinic, Mtendere clinic 
and N’gombe clinic. These thirteen health centres which are geographically evenly distributed across 
the zones and the Lusaka District, offer a comprehensive level of health care and represent the entire 
Lusaka District catchment population-see the Lusaka District facility map and catchment populations 
in Appendix 4. 
 
The other seven health centres, designated as small health centers, were selected using systematic 
random sampling from the remaining seventeen health centers. The sampling interval was 2.43; the 
starting point was randomly chosen as one; and the sequence selected was 1, 4, 6, 9, 11, 14, and 16. 
See the sampling frame in appendix 4 for the primary level health facilities. Approximately one 
health facility was sampled from each of the eight designated district zones. The seven small health 
centers selected were Airport clinic, Chaisa clinic, Lilayi clinic, Mandevu clinic, Civic center clinic, 
St. Agness clinic and State house clinic. Civic center clinic was found to have closed and was no 
longer operational and it was conveniently replaced by Railway clinic. Approximately one health 
facility was sampled from each of the eight designated district zones.  
 
ii. Patients 
 
From each of the 20 health facilities 40 patient encounters were sampled, with a total of 800 patient 
encounters sampled. Twenty (20) patient encounters were sampled for the prescribing practices and 
20 patient encounters were sampled for dispensing practices in each health facility. For these 
encounters convenience sampling was employed. Twenty (20) random patients leaving the dispensary 
and 20 patients leaving the consultation room were interviewed, somewhere around the dispensing 
area or pharmacy consultation room respectively. In order to capture a general patient population, 
patients attending special clinics were not included in the study. 
 
The time needed to conduct the patient interviews was determined by whether consecutive patients 
were recorded and how many patients who had passed through the system were skipped. As much as 
possible, the patient sampling and interviews were spread evenly throughout the day; however, this 
was not always practical. 
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iii. Availability of antimicrobials 
 
Availability of antimicrobials was measured using a key indicator antimicrobial medicines list of 15 
antimicrobials adapted from the communicable disease prevalence data for Lusaka District (Appendix 
5). Availability of antimicrobials over the past year, (January to December, 2015) were determined by 
calculating the proportion of months each of the key indicator essential antimicrobial medicines was 
out of stock for any part of the month during the period under study (January-December, 2015). Some 
of the key indicator drugs have alternate substitute drugs which will also be considered for 
availability. This totals to 26 antimicrobials (15 primary antimicrobial plus 11 substitutes) for each 
facility. Therefore, 520 inventory records for each of these first line and second line medicines were 
examined. 
 
3.5. Data collection  
 
 
The data collection forms are numbered and labeled in Appendix 1. These forms have been adapted 
from the WHO drug use data collection forms (WHO, 1993).  
 
Tool 1: Prescribing Indicator Form (Appendix 1) was used to collect prescribing data. The patients 
were first observed from outside the prescribers’ room for consultation time (minutes). The 
prescribing data collected included the age (years), number of medicines prescribed, number of 
antimicrobials prescribed, number of injectable antimicrobials prescribed, the name(s) of 
antimicrobials prescribed and whether they are on the EML; and the diagnosis.  
 
Tool 2: Patient Care (Pharmacy) Form (Appendix 1) was used to record dispensing data. The 
patients were first observed from the dispensing area for dispensing time-then each patient was 
interviewed, after consent, for age, number of medicines and antimicrobials prescribed and dispensed, 
and the knowledge of dosage and labeling of antimicrobials.  
 
Tool 3: Antimicrobial Availability Form for the year 2015 (Appendix 1) for recording data for the 
availability of the key indicator antimicrobials and their substitutes; how many months in the year 
under study (2015) were the key indicator antimicrobials and their substitutes available. If the 
 
 
 
 
22 
 
antimicrobial was available the entire month it was ticked, and crossed out if not. Red pen was used 
for the primary antimicrobial agent and black pen for the substitute antimicrobial. For missing data, 
nothing was indicated. The stock on hand of the primary antimicrobial agent and its substitute on the 
data collection day was recorded (all the strengths, formulations, and units of the antimicrobial 
medicine available). This information was collected from the stock control cards of the key indicator 
medicines for the year 2015.  
 
Tool 4: Facility Indicator Consolidation Reporting Form (Appendix 1) was used for consolidating 
the data collected for each health facility under study.  
 
Tool 5: Facility Medicines Use Indicator Consolidation Form (Appendix 1) was used for the 
consolidation of the drug use data for the entire study. 
 
The health center in-charges were asked to indicate the primary qualifications of the most senior 
prescriber and the dispenser working on the data collection day.  
 
Third year (final) Pharmacy Technology students from Evelyn Hone College were used as data 
collectors, due to their familiarity with pharmaceutical terms, antimicrobial medicines, and patient 
and prescribing information. Fourteen (14) third year Pharmacy Technology students were trained by 
the researcher (myself) as data collectors for three days according to the “Model Training Course For 
Data Collectors” (Appendix 6) (WHO, 1993). At the end of the training, the data collection tools 
were pre-tested at Evelyn Hone health post, which was not part of the study, for the appropriateness, 
and revisions and corrections made to forms and data collection procedures. “Facility name”, 
“Facility Size” and “Investigator” details were generally removed from the headers of all data 
collection forms. A column for “Consultation time” was added to the “Prescribing indicator Form” 
and the “Facility Indicator Consolidation Reporting Form” respectively; and a column for 
“Dispensing time” was added to the “Facility Indicator Consolidation Reporting Form”. The data 
collection procedure for the availability of antimicrobials was adjusted to include 
alternative/substitute antimicrobial available when the first line antimicrobials are out of stock. 
Therefore, the header information for the “Antimicrobial Availability Form” was adjusted to include 
“Formulation” and “Strength” in place of “Dosage Form”-and “Name of Alternative/Substitute 
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Antimicrobial” was also added to the header information. Furthermore the “Antimicrobial 
Availability Form” was redesigned to include the four weeks of each of the 12 months of the year, 
and each week with two columns-one column for first line antimicrobial and the other column for the 
alternative/substitute antimicrobials respectively. Finally a row for “Percentage availability of second 
line key indicator medicines” was added to the “Facility Indicator Consolidation Reporting Form”; 
whereas a column for “% of Second Line AMCs in Stock” was included in the “Facility Medicines 
Use Indicator Consolidation Form”, respectively. 
 
3.6. Data management and analysis 
 
 
Data entered in each form was counterchecked for recording errors immediately after an encounter 
and consolidated after each data collecting day for each primary level health facility. Quantitative 
data was categorized into continuous numerical variables. Calculations were done manually and using 
computerized analysis (Epi Info package) and presented as simple frequencies and means.  
 
For the individual indicators, analysis and processing were as follows: 
Prescribing indicators (appendix 2): average number and percentages of medicines prescribed per 
patient and per facility; percentage of encounters with an antimicrobial prescribed; percentage of 
medicines present on the essential medicines list (EML) and percentage of injectable antimicrobials 
prescribed. Patient care indicators (appendix 2): percentage of drugs actually dispensed; percentage 
of drugs adequately labeled; and percentage knowledge of dosage. Labeling score: was calculated by 
considering five essential dispensing quality attributes: expiry date, generic name, strength, dosage 
and quantity of the drug. Adequate knowledge of dosage: was limited to patients’ recall of the dose 
(drug quantity), the frequency of administration (time intervals and/or the actual times), the duration 
of treatment and the reason for prescription for each drug prescribed. Health facility indicators: 
availability of key medicines-the availability of the key indicator first line antimicrobials were 
compared with the availability of second line (substitute) antimicrobials-availability of the second 
line antimicrobials was analyzed in respect to when the first line key indicator antimicrobials were 
out of stock. The availability of the copy of essential medicines list or formulary was tallied and 
quantified-the tally indicator was a ‘yes’ or ‘no’.  
 
 
 
 
 
24 
 
3.7. Validity and reliability 
Validity and reliability was ensured through the use of standardized tools which have been adapted 
from validated WHO tools (WHO, 1993). The tools were pretested at Evelyn Hone College Clinic 
which is a health post of Railway Clinic, prior to the commencement of the study, and the necessary 
adjustments made to the data collection tools (as indicated under “Data Collection”). Data collection 
was carried out by trained pharmacy technology students to ensure uniformity. Data forms were 
checked for accuracy at the end of each day at each health centre and cleaned and checked before data 
analysis. In order to capture a general patient population, patients attending special clinics were not 
part of the study. It was important to indicate the different sizes of the health facilities under study on 
the data collection forms because the differences in staffing and services offered may account for the 
differences in the results among the small, medium and large health facilities. Furthermore, the 
qualifications of both the dispensers and the prescribers working on the data collection day were 
captured in order to account for the facility size-dependent quality of services variations. The names 
of the antimicrobials prescribed were recorded in order to confirm that they are indeed antimicrobials, 
their classification (azole creams and artemisinin based treatments), and also for the purposes of 
comparing with the EML. If there were fewer than 40 patient encounters per day in a particular 
facility all the eligible encounters were recorded-this happened at Airport clinic, whereby all the 40 
eligible patients who were seen on the data collection day were included in the study. Therefore, no 
sampling of patients was done at Airport clinic (WHO, 1993).  
 
3.8. Limitations 
 
The main limitation of this study is the risk of observer bias. Observer bias was minimized by the 
precise day of the visits of the data collection team being unannounced, and during the consultations 
and dispensing there was no interference by the research team members. Some of the health facilities 
may have heard rumors about the ongoing study, anticipating a possible visit by the research team. 
This may have resulted in a more favorable outcome than otherwise would have been the case. 
Therefore, the possibility that the research process in itself may have contributed to improving the 
quality of health care provided cannot be excluded. 
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Seasonal variations in the use of antimicrobials will be difficult to account for as the prescribing and 
dispensing (patient care) indicators were measured prospectively. Some of the indicators such as 
patient consultation and dispensing times could have been confounded by patient congestion which 
was not measured in the study.  
Since the term “antimicrobials”, which is used in the study, also includes antiviral medicines, it is 
noteworthy that patients receiving antiretroviral medicines were excluded from the study. However, 
other antiviral medicines for any other viral infection, such as herpes, were included in the study. 
Nevertheless, no other antiviral medicines were prescribed for any of the 800 patient encounters 
recorded in the study. 
 
3.9. Ethics 
 
 
Ethical clearance for the study was obtained from University of the Western Cape Senate Research 
Committee. Permission was obtained from the Lusaka Provincial and District health offices, being the 
authorities that are overseeing the health facilities included in the study. Furthermore, permission was 
obtained from the health center in-charges. Since the involvement of the healthcare providers was 
limited to observation and a mere indication of whether they possess an EML or not, only verbal 
consent was obtained from them. The patient respondents were presented with a Participation 
Information Sheet (Appendix 7), and requested to sign a Consent Form (Appendix 8). These forms 
were translated from English into Nyanja which the main is local language spoken in Lusaka District, 
and patients were offered forms in this language or English. The Patient Information Sheet stated the 
purpose of the study, assuring confidentiality, and that they could withdraw at any stage of the study, 
should they choose so, without any repercussions or harm. The patients were also informed of the 
potential risks associated with participating in this study. A service was provided to any participants 
that needed counseling or referral for care, and contact details were provided to the participants who 
sought any further enquiry. The results of the study will be disseminated to the District Health Office, 
which will be responsible disseminating the results the established government structures. 
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CHAPTER 4: RESULTS 
 
4.1. Introduction 
 
This chapter describes the findings of the study to assess rational use and availability of 
antimicrobials at primary level health facilities in Lusaka District, Zambia. Twenty (20) health 
facilities were sampled and studied, comprising eight large health centers, five medium health centers 
and seven small health centers. This study analyzed 800 patient encounters (40 patient encounters per 
health centre), 520 medicines inventory records (for 15 key indicator medicines and 11 substitutes in 
each of the 20 health facilities) over a 12 month period in 2015 using the WHO standard indicators of 
rational medicines use. Suitably designed forms were employed to collect prescribing and dispensing 
data and antimicrobial availability data for the year 2015 and the data were consolidated on 
designated data consolidation forms.  
 
 
4.2. Study facilities, prescribers and dispensers 
 
 
Table 1 provides a description of the study facilities, prescribers and dispensers included in the study. 
In most facilities Clinical Officers were the most senior prescriber at the facility, with smaller 
numbers having Medical Doctors and Registered Nurses fulfilling these roles. On the other hand, 
Pharmacy Technologists were the most senior dispensers at the vast majority of the facilities, with a 
few Nurses and one Pharmacy Dispenser at some facilities. There were no Pharmacists present at any 
of the facilities during the study period. 
 
Clinical officers in Zambia obtain a Diploma qualification and therefore, their scope of prescribing 
medicines is limited, and more appropriately suited for the primary health care facilities. Nurses 
however, are not generally designated prescribers, unless in selected emergencies. On the other hand, 
and under the current human resource crisis in Zambia, nurses have been known to prescribe outside 
their approved, limited prescribing limit, in some cases. Similarly, for the dispensers, pharmacy 
technologists obtain a diploma qualification, and are only required to work under the supervision of a 
pharmacist, either directly or remotely-as is the case for the pharmacy technologists stationed at the 
primary health facilities. Pharmacy dispensers in Zambia obtain a certificate in pharmacy dispensing, 
and are therefore assistants of the pharmacist and the pharmacy technologist. 
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Table 1: Description of study facilities, prescribers and dispensers 
 
 
Seq. Facility name Facility size Most senior 
Prescriber at Facility 
Most senior 
Dispenser in 
Dispensary  
1.  Chawama 1st Level Hospital Large Sub-center Doctor  Pharm. Tech. 
2.  Chelstone Clinic Large Sub-center Clinical Officer Pharm. Tech. 
3.  Chilenje Clinic Large Sub-center Clinical Officer Pharm. Tech. 
4.  Chipata Clinic Large Sub-center Doctor  Pharm. Tech. 
5.  Kalingalinga Clinic Large Sub-center Clinical Officer Pharm. Tech. 
6.  Kamwala Clinic Large Sub-center Clinical Officer Pharm. Tech. 
7.  Kanyama Clinic Large Sub-center Doctor Pharm. Tech. 
8.  Matero Ref. Clinic Large Sub-center Clinical Officer Pharm. Tech. 
 
9.  Bauleni Clinic Medium Sub-center Clinical Officer Pharm. Tech. 
10.  George Clinic Medium Sub-center Clinical Officer Pharm. Tech. 
11.  Kabwata Clinic Medium Sub-center Doctor  Pharm. Tech. 
12.  Mtendere Clinic Medium Sub-center Reg. Nurse Pharm. Tech. 
13.  N’gombe Clinic Medium Sub-center Clinical Officer Pharm. Tech. 
 
14.  Airport Clinic Small health center Reg. nurse Reg. Nurse 
15.  Chaisa Clinic Small health center Reg. nurse Pharm. Tech. 
16.  Lilayi Clinic Small health center Doctor  Pharm. Tech. 
17.  Mandevu Clinic Small health center Clinical Officer Enrolled Nurse 
18.  Railway Clinic Small health center Clinical Officer Dispenser 
19.  St. Agness Clinic Small health center Reg. nurse Pharm. Tech. 
20.  State House Clinic Small health center Clinical Officer Pharm. Tech. 
 
Overall Statistics Number Percentage  
Prescribers  Medical Doctors 5 25 % 
Clinical Officers 11 55 % 
Registered Nurses 4 20 % 
Dispensers Pharmacists  0 0 % 
Pharmacy Technologists 17 85 % 
Pharmacy Dispensers 1 5 % 
Nurses 2 10 % 
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4.3. Study patients 
 
Of the eight hundred patients included in the study, about one third of all the patients were below 12 
years and the other two thirds were adults above 12 years. In this study, the 12 year cut-off was 
selected as the recommended dosing schedule for most, if not all, antimicrobials, for 12 year old 
patients is the minimum recommended adult dosage of the respective antimicrobial. See Table 2 
below. Forty percent of the patients seen at the small health centers were children, whereas the 
medium health centers saw more adult patients in comparison. Most detailed analyses of the age 
distribution of patients by facilities and facility size/type are shown in Figures 1 and 2 respectively. 
 
Table 2: Description of study patients 
 
Seq. Facility name Facility size Children (0-12yrs) Adult (>12 yrs)  
1.  Chawama 1st Level Hospital Large Sub-center 4 36 
2.  Chelstone Clinic Large Sub-center 14 26 
3.  Chilenje Clinic Large Sub-center 10 30 
4.  Chipata Clinic Large Sub-center 4 36 
5.  Kalingalinga Clinic Large Sub-center 19 21 
6.  Kamwala Clinic Large Sub-center 12 28 
7.  Kanyama Clinic Large Sub-center 14 26 
8.  Matero Ref. Clinic Large Sub-center 21 19 
Sub-Total  98 222 
Percentage  30.6 % 69.4 % 
 
9.  Bauleni Clinic Medium Sub-center 4 36 
10.  George Clinic Medium Sub-center 5 35 
11.  Kabwata Clinic Medium Sub-center 11 29 
12.  Mtendere Clinic Medium Sub-center 14 26 
13.  N’gombe Clinic Medium Sub-center 15 25 
Sub-Total  49 151 
Percentage  24.5 % 75.5 % 
14.  Airport Clinic Small health center 8 32 
15.  Chaisa Clinic Small health center 15 25 
16.  Lilayi Clinic Small health center 18 22 
17.  Mandevu Clinic Small health center 37 3 
18.  Railway Clinic Small health center 7 33 
19.  St. Agness Clinic Small health center 12 28 
20.  State House Clinic Small health center 15 25 
Sub-Total  112 168 
Percentage  40.0 % 60.0 % 
TOTAL  259 541 
OVERALL PERCENTAGE  32.4 % 67.6 % 
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Figure 1: Age distribution of patients (n = 800) by facilities 
 
 
 
 
 
Figure 2: Age distribution of patients (n = 800) by facility size/type 
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4.4. Antimicrobial prescribing information  
 
 
4.4.1. Frequency of prescibing of anti-infective agents 
 
 
Out of the 800 patient encounters, 290 (36.3%) encounters involved antimicrobials (anti-infective 
agents) (see Figure 3 and Table 4). Amoxicillin and Metronidazole were by far the most commonly 
prescribed antimicrobials at 32.0 % and 17.2% respectively; both combining to account for half 
(49.3%) of all patient encounters with anitimicrobials. Amoxicillin was almost exclusively prescribed 
for coughs which accounted for 37.8% of all diagnoses, whereas Metronidazole was mostly 
prescribed for diarrhea which accounted for 19.4% of all diagnoses for which antimicrobials were 
prescribed. 
 
Benzyl penicillin, benzathine penicillin and gentamycin injections were the only injectable 
antimicrobials prescribed at all the health facilities with an average of 1.8%, 0.3% and 0.9% 
respectively. 
 
 
Figure 3: The 10 most commonly prescribed anti-infective agents (338) 
 
 
 
 
 
These 10 anti-infective agents illustrated in Figure 4 accounted for 90.1 % of all patient encounters 
with antimicrobials.  
 
 
 
 
 
 
31 
 
Table 3: Frequency of prescribing of anti-infective agents 
 
 
SN ANTIMICROBIAL NAME FREQUENCY PERCENTAGE 
1.  Amoxicillin  108 32.0 % 
2.  Metronidazole  58 17.2 % 
3.  Doxicycline  28 8.3 % 
4.  Erythromycin  28 8.3 % 
5.  Cloxacillin  18 5.3 % 
6.  Penicillin V 18 5.3 % 
7.  Ciprofloxacin  16 4.8 % 
8.  Artemether/lumefantrine 13 3.8 % 
9.  Clotrimazole cream 9 2.7 % 
10.  Cephalexin 8 2.4 % 
11.  Benzyl penicillin injection 6 1.8 % 
12.  Mebendazole  5 1.5 % 
13.  Nalidixic acid 3 0.9 % 
14.  Gentamycin injection 3 0.9 % 
15.  Chloramphenicol eye drops 3 0.9 % 
16.  Co-trimoxazole  2 0.6 % 
17.  Fluconazole capsules 2 0.6 % 
18.  Tetracycline eye drops 2 0.6 % 
19.  Ketoconazole cream 1 0.3 % 
20.  Gentamycin eye drops 1 0.3 % 
21.  Silver sulfadiazine cream 1 0.3 % 
22.  Albendazole  1 0.3 % 
23.  Chlorampenicol capsules 1 0.3 % 
24.  Tinidazole tablets 1 0.3 % 
25.  Cefuroxime  1 0.3 % 
26.  Benzathine penicillin injection 1 0.3 % 
TOTAL NUMBER OF AMCs 338 100.30 % 
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4.4.2. Common diagnoses associated with use of anti-infective agents 
 
 
Overall, 90.6 % (197) of all the diagnoses (217) associated with anti-infective agents were coughs, 
diarrhea, respiratory/chest symptoms, urinary tract infections, ear symptoms, abdominal pains, eye 
symptoms, throat symptoms and sexually transmitted infections. About half (49.3%) of all diagnoses 
were respiratory in nature (coughs and RTI/chest pain) (see Table 4). 
 
Table 4: Common diagnoses associated with anti-infective agents 
 
 
SN DIAGNOSIS  FREQUENCY PERCENTAGE 
1.  Cough 82 37.8 % 
2.  Diarrhoea  42 19.4 % 
3.  RTI/chest pain 25 11.5 % 
4.  UTI 15 6.9 % 
5.  Ear infection 8 3.7 % 
6.  Abdominal pain 7 3.2 % 
7.  Eye infections 7 3.2 % 
8.  Throat infections 6 2.6 % 
9.  STIs 5 2.3 % 
10.  Tissue infections 5 2.3 % 
11.  Fever  4 1.8 % 
12.  Worm infestations 4 1.8 % 
13.  Vaginal yeast infections 3 1.4 % 
14.  Athletes foot 2 1.0 % 
15.  Burns  1 0.5 % 
16.  Acne  1 0.5 % 
TOTAL 217 99.90 % 
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Figure 4: Top 10 diagnoses associated with use of anti-infective agents (n = 217) 
 
 
 
 
 
 
 
4.4.3. Antimicrobial prescribing practices  
 
 
Antimicrobial prescribing practices are summarized in Table 5. The practice of polypharmacy 
(average of 2.94 medicines per prescription), was found at all primary health facilities in the study - 
small, medium. The average percentage of antimicrobials prescribed by generic name was low at 
33.6%, with a wide range form 0-73.3%. The large sub-centers recorded the highest use of generic 
names (42.0%), while the medium sub-centers (32.6%) and small health centers (33.6%) averaged 
lower. 
 
The overall average percentage of antimicrobials prescribed was relatively high (36.2%) with the 
highest seen at Chawama first level hospital (formerly clinic) (73.0%). In comparison, the large sub-
centers recorded the highest average percentage (40.6%), followed by the medium sub-centers 
(35.6%), then the small health centers averaged lowest (31.4%).  
 
The overall average percentage of injectable antimicrobials prescribed was considerably modest 
(3.4%), except for Lilayi (13.3%), Kabwata (15.0%) and Kanyama (20.0%) Clinics where the use of 
injectable antimicrobials was much higher in comparison to the rest of the clinics studied. Overall, the 
large sub-centers comparably used more injectable antimicrobials (4.1%) than the medium sub-
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centers (3.0%) and small health centers (2.7%) which averaged comparably. Patients receiving 
antiretroviral medicines were excluded from the study. Whilst patients receiving antiretroviral 
medicines were excluded from the study, it should be noted that no other antiviral medicines were 
prescribed in all the 800 patient encounters recorded. 
 
The average percentage of antimicrobials prescribed which were on the essential medicines list 
(EML) was moderate (75.4%). For antimicrobials which were out of stock, prescriptions were written 
for the patients to purchase the medicines from the private pharmacies. Airport clinic recorded the 
lowest (33.0%) prescribing adherence to the essential medicines list. The large sub-centers recorded 
the highest (85.0%) adherence to prescribing according to the EML, with the medium sub-centers 
(74.0%) and small health centers (75.4%) recording similar but lower adherence to the EML.  
 
The average consultation time was short, at four minutes. The least average consultation time was 
recorded for Bauleni (1 minute) and Airport (1 minute) clinics while Chaisa clinic (8.4 minutes) 
recorded the highest average consultation time. The consultation times for the large sub-centers (4.3 
minutes) were comparable to that of the small health center (4.4 minutes). However, the distribution 
of the consultation time of the small health centers was very uneven, with clinics recording both the 
overall shortest and the longest consultation times. The average consultation time for the medium 
sub-center was the shortest. 
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Table 5: Antimicrobial prescribing practices (n = 217) 
 
 
Seq Facility Facility size Av. No. 
of  
Meds 
per 
prescript
ion (Rx) 
Av. %  
Generic
s AMCs 
on the 
Rx  
Av. % 
AMCs 
on the 
Rx 
Av. % 
of Inj. 
AMCs 
on the 
Rx  
% 
AMC 
on 
EML 
Av. 
Consult. 
Time 
(mins) 
1.  Chawama 1st Level 
Hospital 
Large Sub-center 3 51 73 2 70 3 
2.  Chelstone Clinic Large Sub-center 3 100 47 6 90 5 
3.  Chilenje Clinic Large Sub-center 2.3 21 43 0 85 2.7 
4.  Chipata Clinic Large Sub-center 3 19 32 0 80 4 
5.  Kalingalinga Clinic Large Sub-center 3 27 29 0 75 4 
6.  Kamwala Clinic Large Sub-center 3 30 30 0 100 4 
7.  Kanyama Clinic Large Sub-center 4 63 35 20 100 5 
8.  Matero Ref. Clinic Large Sub-center 3 25 36 5 80 7 
Group-Mean  3.04 42 40.6 4.1 85 4.3 
Group Maximum 4 100 73 20 100 7 
Group Minimum 2.3 19 30 0 70 2.7 
 
9.  Bauleni Clinic Medium Sub-center 3 30 28 0 55 1 
10.  George Clinic Medium Sub-center 2.9 71 48 0 80 4.1 
11.  Kabwata Clinic Medium Sub-center 3 15 29 15 65 3 
12.  Mtendere Clinic Medium Sub-center 3 11 33 0 70 4 
13.  N’gombe Clinic Medium Sub-center 2.85 36 40 0 100 4 
Group-Mean  2.95 32.6 35.6 3.0 74 3.2 
Group Maximum 3 71 40 15 100 4.1 
Group Minimum 2.9 15 28 0 55 1 
 
14.  Airport Clinic Small health center 2 0 14 0 33 1 
15.  Chaisa Clinic Small health center 2.35 36 49 0 70 8.4 
16.  Lilayi Clinic Small health center 3.75 73.3 21.4 13.3 70 6.2 
17.  Mandevu Clinic Small health center 2.7 58.8 33 5.9 60 4.1 
18.  Railway Clinic Small health center 3 30 31 0 80 3 
19.  St. Agness Clinic Small health center 3 20 49 0 70 4 
20.  State House Clinic Small health center 3 17 24 0 55 4 
Group-Mean  2.83 33.6 31.6 2.7 62.6 4.4 
Group Maximum 3.75 73.3 49 13.3 80 8.4 
Group Minimum 2 0 14 0 33 1 
 
Mean   2.94 36.7 36.2 3.4 75.4 4.0 
Maximum  3.75 100 73 20 100 8.4 
Minimum  2 0 14 0 33 1 
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Table summary 
 Average number of medicines prescribed per prescription was 2.94 (Range, 2 – 3.75 medicines) 
 Out of the 20 sampled clinics, 14 (70%) prescribed 3 or more medicines per prescription 
 Average percentage of AMCs prescribed by generic name was 36.7 % (Range, 0 – 100%) 
 Average of percentage AMCs prescribed was 36.2 % (Range, 14 – 73%) 
 Percentage of injectable AMCs prescribed was 3.4 % (Range, 0 – 20%) 
 Percentage of AMCs prescribed which were on the EML was 75.4 % (Range, 33 – 100%) 
 Average consultation time was 4.0 minutes (Range, 1- 8.4 minutes 
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4.5. Antimicrobial dispensing practices 
 
 
A summary of antimicrobial dispensing practices is shown in Table 6. Generally, the dispensing 
times were short with the mean dispensing time for the primary level health facilities being 116.6 
seconds. According to the facility sizes, the large sub-centers recorded the shortest average 
dispensing time (102.0 seconds), while the medium sub centers and the small health centers recorded 
higher comparable dispensing times at 125.6 and 126.9 seconds respectively.  
 
The mean percentage of antimicrobials actually dispensed was low, whereby only about half (54.3%) 
of the antimicrobials prescribed were actually dispensed. The large sub-centers recorded the highest 
percentage of antimicrobials actually dispensed (61.9%), followed by the small health centers 
(54.1%), then the medium sub-centers with the lowest (42.4%).  
 
The overall mean percentage of medicines packages correctly labeled was rather low (44.8%). Patient 
information was not adequately re-enforced by the medicines labels, and the labels did not provide 
information to patients who may have forgotten or did not understand dosing instructions. The large 
and medium sub-centers recorded comparably lower percentages of correctly labeled medicines 
packs¸ at 39.6% and 37.0% respectively. Interestingly, the small health centers had the highest 
average numbers of medicines correctly labeled (56.3%).  
 
The overall mean percentage of patients with adequate knowledge of dosage was low, with less than 
half (46.7%) of the patients having adequate knowledge of dosage. The medium health centers 
recorded the lowest percentage of adequate knowledge of dosage. 
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Table 6: Antimicrobial dispensing practices (n = 338) 
 
Seq. Facility Facility size Average 
Dispensing 
time 
Percentage 
of AMCs 
Dispensed 
Percentage 
correctly 
labeled 
Percentage 
of adequate 
knowledge 
1.  Chawama 1st Level 
Hospital 
Large Sub-center 162 49 35 35 
2.  Chelstone Clinic Large Sub-center 129 92 84 57 
3.  Chilenje Clinic Large Sub-center 130 100 42 46 
4.  Chipata Clinic Large Sub-center 72 65 47 37 
5.  Kalingalinga Clinic Large Sub-center 66 61 36 65 
6.  Kamwala Clinic Large Sub-center 100 42 14 49 
7.  Kanyama Clinic Large Sub-center 117 36 3 58 
8.  Matero Ref. Clinic Large Sub-center 40 50 56 55 
Group-Mean  102.0 61.9 39.6 50.3 
Group Maximum 130 100 84 65 
Group Minimum 40 36 3 35 
 
9.  Bauleni Clinic Medium Sub-center 15 39 37 21 
10.  George Clinic Medium Sub-center 246 18 60 40 
11.  Kabwata Clinic Medium Sub-center 130 78 41 23 
12.  Mtendere Clinic Medium Sub-center 72 37 25 48 
13.  N’gombe Clinic Medium Sub-center 165 40 22 51 
Group-Mean  125.6 42.4 37.0 36.6 
Group Maximum 246 78 60 51 
Group Minimum 15 18 22 21 
 
14.  Airport Clinic Small health center 60 14 92 15 
15.  Chaisa Clinic Small health center 31 64 72 80 
16.  Lilayi Clinic Small health center 360 73 70 60 
17.  Mandevu Clinic Small health center 110 25 45 55 
18.  Railway Clinic Small health center 144 100 48 64 
19.  St. Agness Clinic Small health center 120 51 37 56 
20.  State House Clinic Small health center 63 52 30 21 
Group-Mean  126.9 54.1 56.3 50.1 
Group Maximum 360 100 92 80 
Group Minimum 31 14 30 15 
 
Mean   116.6 54.3 44.8 46.7 
Maximum  360 100 92 80 
Minimum  15 14 3 15 
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Table summary 
 The mean dispensing time for the primary level health facilities was 116.6 seconds (Range, 
15–360 seconds) 
 The mean percentage of antimicrobials actually dispensed was 54.3 % (Range, 14 – 100 %) 
 The mean percentage of drug packages correctly labeled was 44.8 % (Range, 3 – 92 %) 
 The mean percentage of patients with adequate knowledge of dosage was 46.7 % (Range, 15 – 
80 %) 
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4.6. Antimicrobial availability  
 
Table 7 provides information on antimicrobial availability at the 20 health centres showing that the 
average percentage of first line antimicrobials available during the year, 2015, was moderate, with 
comparable figures for the large, medium sub-centers and small health centers respectively. 
 
On the other hand, the average percentage of second line substitute antimicrobials available during 
the year 2015 was exceedingly low. Understandably, Chawama first level hospital recorded the 
highest availability of substitute antimicrobials, having recently been upgraded to a first level 
hospital. As expected, the large sub-centers generally recorded the highest mean availability, which 
was at 19.9% was still very low, while the medium sub-center and the small health centers recorded 
mean availabilities of substitute antimicrobials of 10.2 % and 12.6 % respectively, based on an 
average 48 week per year period.  
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Table 7: Antimicrobial availability for the year 2015 
 
Seq. Facility name Facility size  Percentage 
of 1
st
 line 
AMCs 
In stock 
Percentage of 
2
nd
 line 
AMCs 
In stock 
1.  Chawama 1st Level Hospital Large Sub-center  87 48 
2.  Chelstone Clinic Large Sub-center  68 17 
3.  Chilenje Clinic Large Sub-center  76 0 
4.  Chipata Clinic Large Sub-center  69 26 
5.  Kalingalinga Clinic Large Sub-center  89 20 
6.  Kamwala Clinic Large Sub-center  85 8 
7.  Kanyama Clinic Large Sub-center  64 13 
8.  Matero Ref. Clinic Large Sub-center  89 27 
Group-Mean  78.4 19.9 
Group Maximum 89 48 
Group Minimum 64 0 
9.  Bauleni Clinic Medium Sub-center  76 1 
10.  George Clinic Medium Sub-center  79 13 
11.  Kabwata Clinic Medium Sub-center  85 14 
12.  Mtendere Clinic Medium Sub-center  86 7 
13.  N’gombe Clinic Medium Sub-center  83 16 
Group-Mean  81.8 10.2 
Group Maximum 86 16 
Group Minimum 76 1 
14.  Airport Clinic Small health center  86 20 
15.  Chaisa Clinic Small health center  64 7 
16.  Lilayi Clinic Small health center  80 22 
17.  Mandevu Clinic Small health center  68 13 
18.  Railway Clinic Small health center  83 13 
19.  St. Agness Clinic Small health center  77 6 
20.  State House Clinic Small health center  79 7 
Group-Mean  76.7 12.6 
Group Maximum 86 22 
Group Minimum 64 7 
Mean  79 15 
Maximum 89 48 
Minimum 69 0 
 
Note: the mean availabilities of the first line and substitute antimicrobials of 10.2 % and 12.6 % 
respectively were determined based on an average 48 week per year period. The unit period was a 
week-if a medicine was recorded as available even for a single day in that week, it was considered the 
available for that whole week. 
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4.7. Essential medicines list  
 
A copy of the EML was available in most (80%) of the primary health facilities –see Table 8. 
 
Table 8: Essential medicines list 
 
 
Seq. Facility name Facility size Availability of EML (Y/N) 
1.  Chawama 1st Level Hospital Large Sub-center No 
2.  Chelstone Clinic Large Sub-center Yes 
3.  Chilenje Clinic Large Sub-center Yes 
4.  Chipata Clinic Large Sub-center Yes 
5.  Kalingalinga Clinic Large Sub-center Yes 
6.  Kamwala Clinic Large Sub-center Yes 
7.  Kanyama Clinic Large Sub-center Yes 
8.  Matero Ref. Clinic Large Sub-center Yes 
 
Group-Mean  
Group Maximum 
Group Minimum 
9.  Bauleni Clinic Medium Sub-center Yes 
10.  George Clinic Medium Sub-center No 
11.  Kabwata Clinic Medium Sub-center Yes 
12.  Mtendere Clinic Medium Sub-center No 
13.  N’gombe Clinic Medium Sub-center Yes 
 
Group-Mean  
Group Maximum 
Group Minimum 
14.  Airport Clinic Small health center Yes 
15.  Chaisa Clinic Small health center Yes 
16.  Lilayi Clinic Small health center No 
17.  Mandevu Clinic Small health center Yes 
18.  Railway Clinic Small health center Yes 
19.  St. Agness Clinic Small health center Yes 
20.  State House Clinic Small health center Yes 
Group-Mean  
Group Maximum 
Group Minimum 
 
Mean   
Maximum 16 YES 
Minimum 4 NO 
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CHAPTER 5: DISCUSSION 
 
 
5.1. Introduction 
 
 
This prospective and retrospective cross-sectional descriptive study assessed the rational use and 
availability of medicines, focusing on antimicrobial agents at primary level health facilities under the 
Lusaka district community health office, Zambia using the WHO standard indicators of rational drug 
use. The study analyzed 800 patient encounters, 520 medicines inventory records, and other baseline 
data, from 20 health facilities at three different levels, according to size and scope of service delivery.  
The discussion of the findings of the study follows. 
 
 
5.2. Prescribing practices of medicines, including antimicrobials 
 
The study found that 2.94 medicines per encounter were prescribed at the Lusaka District public 
sector health facilities. This was consistently observed in 15 of the 20 sampled clinics – accounting 
for 75% of prescriptions. WHO (2012) recommends a benchmark of 2.0 medicines per encounter. 
According to WHO (1993), the average number of medicines (including injections) prescribed per 
patient encounter is an important index of the scope for educational intervention in prescribing 
practices. Prescribing more than 2.0 medicines per patient encounter increases the risk of drug 
interactions, dispensing errors, and of the patient not knowing the dosage schedules. Similar findings 
have been reported in Asian studies from Cambodia, India, Nepal and Parkistan; and African studies 
from Burkina Faso, Ethiopia, Ghana, Morocco, Nigeria, Tanzania, and Zimbabwe, whereby the 
number of antimicrobials prescribed per patient encounter ranged from 2.2 to 4.8 medicines per 
patient encounter (WHO, 2006). Studies conducted in the USA reported that children are prescribed 
an average of 2.7 medicines per encounter, demonstrating a widespread global concern in prescribing 
of medicines. However, some other Asian studies from Bangladesh and Lebanon have reported 
rational figures of 1.4 and 1.6, respectively (WHO, 2006).  
 
Concerning the prescribing of medicines by generic names, this study found that only 36.2% of 
medicines were prescribed by generic name. The picture portrayed in the study indicates considerable 
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influence of the private pharmaceutical industry on prescribing, whereby prescribers have been 
significantly induced by the drug marketers to prescribe specific brands of medicines. This effectively 
increases the cost of medicines. It also creates a propensity to reduce patient confidence in the 
treatment if the brands prescribed are not the ones dispensed to the patient, and may create an illusion 
that medicines are out of stock at the facility. However, this could easily be mitigated within the 
health facilities if there was collaboration between the prescribers and dispensers. Therefore, 
increasing generic prescribing rationalizes the use and reduces the cost of medicines. Increasing the 
prescribing of  medicines by generic names is a global concern. WHO (2012) recommends that all 
medicines (100%) prescribed should only be by generic name. Asian studies reporting on the Indian 
rational medicines use studies, those from Lebanon, Nepal and Pakistan and African rational 
medicines use studies from Ghana, found the rate of generic prescribing ranging from 2.9% to 65.0%. 
However higher figures ranging from 75% to 99.8% of generic prescribing have been reported from 
Asia (Bangladesh, Cambodia) and Africa (Ethiopia, and Tanzania) (WHO, 2006).  
 
The average use of injections demonstrated in this study was relatively low, at an average of 3.4 %, 
and ranging between 0-20%. However, within the district, inappropriate use of injections was seen at 
Lilayi clinic (13.3%), Kabwata clinic (15%) and the highest at Kanyama clinic (20%). The 
commonest diseases, in their uncomplicated forms, do not generally require injectable medicines; any 
patient who needs an injection would usually be sent to a referral hospital. The use of injections is 
largely influenced by the availability of the injectable medicines and syringes and needles. This was 
actually demonstrable in that among all the 217 diagnoses recorded in the study none of them had 
adequate severity to warrant injectable antimicrobial use, more so that the patients were all out 
patients. For instance, about 80% of all diagnoses for which antimicrobials were prescribed included 
mild to moderate symptoms of cough, diarrhoea, respiratory and urinary tract infection, ear 
infections, abdominal pain, eye infections and throat infections. Unfortunately, inappropriately high 
injection prescribing (17.1% to 80%) has also been reported from Ethiopia, Ghana, Morocco, 
Pakistan, Tanzania, and Zimbabwe (WHO 2006). There remains an urgent need to reduce injection 
use in developing countries.  
 
The use of antimicrobials in Lusaka district was at an average of 36.2% of all prescriptions. 
Comparing this observation with the common diagnoses, 37.8% of all the patients presented with 
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coughs, and 19.4% of all diagnoses presented with diarrhea. In the study all the amoxicillin 
prescribed (32% of total antimicrobials) was for coughs (37.8%), whereas all the metronidazole 
prescribed (17.2 % of total antimicrobials) was for diarrhea (19.4 %). Contrary to this observation, 
most acute respiratory infections in both children and adults are viral and antimicrobials are not 
required, and most acute gastroenteritis cases in children are viral and need only oral rehydration 
therapy (Pichichero et al., 2000). Similar observations are demonstrable for diarrheal diseases in 
adults, most of which are as a result of non-infectious causes and are consequentially self limiting. In 
addition it can be seen that the use of antimicrobials, often inappropriate as in their use for acute 
upper respiratory tract infection and acute diarrhoea, is increasing across the world (WHO, 2012). 
Similar rational medicines use studies in most other Indian studies; and those from Cambodia, 
Ethiopia, Ghana, Morocco, and Nigeria, reported a antimicrobial use ranging from 47.5% to 100%. 
On the other hand, lesser figures of antibiotic prescribing ranging from 17.5% to 35.4% have been 
reported from Bangladesh, Lebanon, Nepal, and Tanzania (WHO 2006). Other studies conducted in 
children in Mexico, USA and Canada reported higher figures at 77%, 43% and 74% respectively. 
Other higher figures were reported in other Indian studies (64%); and those from Nigeria, Indonesia, 
Bangladesh, and Pakistan (58% to 96%). However, any drug utilization study based on the WHO 
core drug use indicators has limitations. The quality of diagnosis and evaluating the adequacy of drug 
choices is beyond the scope of the prescribing indicators and the patient care indicators do not capture 
many fundamental issues related to the quality of examination and treatment. 
 
As seen in this study, the average consultation time was universally short at 4.0 minutes, ranging 
from 1- 8.4 minutes. The WHO (2012) recommends that patient consultation time should be at least 
15 minutes. It is well known that adequate consultation time improves the chances of getting a right 
diagnosis. Consultation time has also been associated with the thoroughness of the prescriber in 
determining an appropriate diagnosis to guide prescribing. For instance, WHO (2012) reported that 
less than 60% of children with acute diarrhoea received necessary oral rehydration therapy yet more 
than 40% received unnecessary antimicrobials; only 50% of people with malaria receive the 
recommended first-line antimalarial; only 50–70% of people with pneumonia are treated with 
appropriate antimicrobials, yet up to 60% of people with viral upper respiratory tract infection receive 
antimicrobials inappropriately. For correct diagnosis, clinicians need to spend more consultation time 
in evaluating the signs, symptoms and laboratory investigations. 
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5.3. Dispensing practices of medicines including antimicrobials 
 
Poor dispensing practices are not rare; however, the importance of dispensing is often overlooked. 
Data from the WHO database show that about 80% of all prescribed medicines are dispensed but 
often by unqualified personnel, and hence little or no pharmaceutical counseling is offered. However, 
in this study all the 13 large and medium health centers had at least one pharmacy technologist 
dispensing, and four of the seven small health centers had at least one pharmacy technologist. Despite 
this minimum dispensing professional presence at the primary health facilities, whereby at least one 
pharmacy technologist was present in 85 % of the health facilities, poor dispensing practices were 
observed. This study found that only about half (54.3%) of prescribed medicines were actually 
dispensed, and patients were required to purchase medicines from the private pharmacies. This is 
strongly linked to availability of the EML, essential medicines, and prescribing of medicines on the 
EML, based on prescribed clinical guidelines. Clinical guidelines provide a benchmark of satisfactory 
diagnosis, treatment and dispensing, against which comparison of actual treatments and essential 
medicines availability can be made. This is strongly associated with the availability of the essential 
medicines and an EML. Using an EML makes medicine management easier in all respects; 
procurement, storage and distribution are easier with fewer items, and prescribing and dispensing are 
easier for professionals if they have to know about fewer items (WHO, 2002). The figures reported in 
this study are higher than figures reported in other Indian studies; but lower than those from Burkina 
Faso, Cambodia, and Ethiopia (82% to 100%).  
 
The WHO (2012) recommends that the pharmacists (and pharmacy technologists) should spend at 
least 180 seconds (3 minutes) in orienting each patient. However, the average duration of dispensing 
of 116.6 seconds found in this study is grossly inadequate for proper pharmaceutical orientation. 
Short dispensing times were similarly reported in the Western Nepal (52 seconds), Brazil (18.4 
seconds), and Southwest Ethiopia (80 seconds) studies.  
 
In addition, the average level of appropriate labeling in the district (44.8%) also needs to be 
improved. Although as low as 3% and 14% of dispensed medicines were adequately labeled at 
Kanyama and Kamwala clinics respectively, much higher figures of 84% and 92% were seen at 
Chelstone and Airport clinics respectively.  Writing the patient's name, medicine generic name, 
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expiry date, strength of the medicine, dosage and the quantity of the medicine dispensed on the label 
is a requirement for good pharmacy practice (Boonstra et al, 2003). It would help in reducing the risk 
of dispensing errors, and offer an opportunity to the patient to consult another dispensers in future and 
also keep the record for a future medicine use history should they seek medical or pharmaceutical 
care elsewhere in future. Similar labeling inadequacy was reported in studies conducted in India, and 
Tanzania which recorded 56.2% and 87%, respectively.  
 
In the primary health facilities studied, only half (50.1%) of the patients knew the correct dosage 
schedule. This implies that half of the patients were either not counseled on how to take their 
medicines or even when they were, the patients did not remember. Therefore, this indicates the 
dispensers’ poor predisposition to adequately counsel the patient. This is also consistent with the 
other poor dispensing indicators seen in the study. The dispensers after having explained once should 
request the patients and the parents of the children patients to repeat the medicine dosages. This 
would help identify parents who require to be explained again. The WHO database shows that, on 
average, dispensing time is 60 seconds, only half of patients are told how to take their medicines, 
about one third of patients do not know how to take their medicines immediately on leaving the 
facility, and that 20–50% of medicines dispensed were not labeled. In such circumstances it is not 
surprising that patient adherence to medicines is poor (WHO, 2012). The dispensing process greatly 
influences how medicines are used. An important aspect of rational medicines use is whether or not 
patients adhere to their treatment. Many other studies show that patients are not often adherent to 
their treatment. With regard to antimicrobials, a patient survey in 11 countries medication for acute 
community infections admitted not finishing the therapy. However, adherence rates varied widely 
across the countries. The Asian countries, China and Japan, had the highest admitted non-adherence 
rates and the two European countries, Italy and the Netherlands, the lowest (Pechère et al., 2007).  
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5.4. Availability and access to the essential medicines list 
 
The availability of all key indicator medicines in the district should be ensured. A mean figure of 
79.0% availability of first line key indicator medicines and 15% availability of second line 
antimicrobials was recorded in the study. Higher figures of first line key indicator medicines were 
reported from Cambodia at 86.6%, a lower figure of 54% from Bangladesh, and an optimal figure of 
100% from Ethiopia (WHO, 2006). The lack of availability of key medicines has a significant impact 
on the way and which medicines are prescribed and dispensed.  
 
The average percentage of second line substitute antimicrobials available during the year 2015 was 
15%. Second line antimicrobials are often more expensive, sometimes more efficacious, and may 
have more or less adverse drug reactions than the first line; and are usually associated with higher 
levels of healthcare, such as referral centers of the primary health facilities under study. 
Understandably, Chawama first level hospital (formerly a large health center) recorded the highest 
availability of substitute antimicrobials. Generally, the large sub-centers recorded comparably the 
highest but low average mean availability of 19.9%, while the medium sub-center and the small 
health centers recorded comparable mean availabilities of substitute antimicrobials of 10.2% and 
12.6% respectively. It is not expected that non-availability of substitute will impact medicines use, 
unless in special cases where the first line antimicrobial is not available and the second line substitute 
is available. Therefore, the impact of the second line key indicator antimicrobials at this level of 
healthcare may not be considerable in that the reported disease burden in the study and also the fact 
that the antimicrobials on the EML are adequate to handle the infections. All of this has implications 
for irrational medicine use (WHO, 2012).  
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5.5. Availability of the essential medicines list  
 
Sixteen (16) out of 20 (80%) facilities had the EML to refer to, and comparably 75.4% of the 
medicines prescribed were essential medicines. This is higher than figures reported in most other 
Asian studies (Bangladesh, India, Lebanon, Nepal, Pakistan) and African studies (Burkina Faso, 
Morocco), both ranging from 2.9% to 88%. However, the ideal figures of 100% were also seen at 
Kamwala clinic, Kanyama clinic and Ng’ombe clinics. A locally adapted EML would help promote 
rational medicines use in our outpatient department. However, it is incumbent upon both the 
prescribers and the dispensers in the district health facilities to adhere to the EML. 
 
Currently, as further demonstrated by this study, there is a substantial evidence of continuing 
irrational use of medicines. This is in line with previous global studies in which less than 40% of 
patients in the public sector and less than 30% in the private sector are treated in accordance with 
existing guidelines, and the situation is not improving in either developing or transitional countries 
(WHO, 2011). Despite the global problem of inappropriate use, few countries are monitoring 
medicines use or taking sufficient action to correct the situation (WHO, 2006).  
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CHAPTER 6: CONCLUSIONS AND RECOMMENDATIONS 
 
 
6.1. Conclusions  
 
This medicines use study found considerable overuse and irrational use of antimicrobials in the 
primary health care clinics in Lusaka District.  
 
Irrational medicine prescribing was a common and significant problem in the health care system in 
Lusaka District and this is in line with worldwide trends, in developed and developing countries alike. 
There was oral and parenteral (injectable) antimicrobial overuse at the health facilities studied, 
including prescribing for conditions that do not warrant any antimicrobial use. On the other hand, 
most of the antimicrobials were prescribed by the brand names indicating significant influence from 
the local and international pharmaceutical distributors respectively. This has often increased the 
patients’ cost of treatment, and has also created mistrust of both the prescribers and dispensers by 
patients who do not receive the particular brand prescribed. There was also minimal consultation time 
provided to patients in the consultation room and significantly less time spent on counseling patients 
at the pharmacy. This irrational use has been linked to the lack of knowledge and/or experience of 
health care professionals (prescribers and dispensers), inadequate health care systems, and poorly 
educated (counseled) patients. 
 
Patient knowledge of medicine dosage was very poor and this leads to poor use of and adherence to 
medicines, and poor therapeutic outcomes, and consequently contributes to antimicrobial resistance. 
At least some of this poor patient knowledge can be linked to the considerably shorter dispensing 
times spent by the dispensers at these primary health facilities. In this study, there were significantly 
less labels found that provided complete instructions for the patients. Proper pharmacy labels can 
contribute to better compliance and improved patient understanding of their medications. Therefore, 
interventions are necessary to improve the education and counseling activities to patients by the 
medicines dispensers. 
 
Even though most health facilities had access to the EML, the availability of medicines at these 
primary health facilities was inadequate. Some facilities appeared to have an unnecessarily high 
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injectable antimicrobials usage, instead of either referring such patients or simply adhering to the 
treatment guidelines. Out of stock medicines is problematic and some medicines were not available 
for use in primary health facilities and hospitals. Standards for treating infectious, especially 
respiratory and diarrheal diseases are not adhered to at nearly all the facilities which led to many sub-
optimal treatments for the same medical condition.  
 
Therefore, as is already well known, this demonstrable overuse and abuse of antimicrobials most 
definitely leads to increase in adverse drug reactions, drug interactions, antimicrobial resistance, 
increased health care costs and inadequate therapeutic patient outcomes.  
 
6.2. Recommendations 
 
The following recommendations are proposed: 
 
1) Reinforce the Drug Therapeutic Committees (DTCs) at the national and the local facility level to 
assist with management of medicines by ensuring that the national formulary is followed, 
prescribing is monitored to identify medicine use problems, and interventions are developed and 
implemented to improve use when problems are identified. Furthermore, baseline data gathered 
by this study could be used by researchers and policymakers to improve and monitor 
pharmaceutical regulatory systems, medicine prescribing and dispensing, and consumption 
practices of the antimicrobials.  
 
2) Clarify the roles of prescribers to ensure that only designated prescribers (doctors and clinical 
officers) are allowed to prescribe. Pharmacists should increase their involvement at health facility 
level and work directly with the pharmacy technologists and dispensers. Nurses should focus on 
their nursing roles and should be directly supervised if they are required to engage or assist in 
prescribing or dispensing duties. 
 
3) Develop, enforce or adapt existing Standard Operational Procedures (SOPs) for the dispensing 
process and medicines management systems, and institute the appropriate periodic technical 
support, monitoring and evaluation. The professional body for pharmacists, pharmacy 
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technologists and pharmacy dispensers (the Pharmaceutical Society of Zambia) should be 
advocate for the adherence to SOPs by its members for professional excellence, improved patient 
outcomes, rational medicines use and overall public safety. 
 
4) Improve performance of designated prescribers and dispensers through continuous medical 
education (CME), provision of regular up-to-date medicine information and standard treatment 
guidelines and through regular supportive supervisory visits and therapeutic audits.  
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Appendix 1: Data collection forms. 
 
i. Prescribing indicator form 
Facility Name: …………………………………………. Date: ………………………... 
Qualification:…………………………….. 
 
Seq Age 
(yrs) 
Cons. 
Time 
(mins) 
# of 
meds 
# of 
AMCs  
# of 
AMCs 
Rx by  
Generic 
names 
# of Inj. 
Antimic. 
Rx 
Name (s) of 
AMCs 
prescribed 
Diagnosis On EML 
(Y/N) 
1.           
2.           
3.           
4.           
5.           
6.           
7.           
8.           
9.           
10.           
11.           
12.           
13.           
14.           
15.           
16.           
17.           
18.           
19.           
20.           
Total  N/A         
Aver. N/A    N/A N/A N/A N/A N/A 
Percent   % of 
total 
drugs 
% of 
total 
drugs 
% of 
total 
cases 
% of 
total 
cases 
% of total 
drugs 
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ii. Patient care (pharmacy) form 
 
Facility Name:……… Qualification of Dispenser:……… Possess a copy of EML (Y/N): ……… 
Labeling and Knowledge of dosage Scores (0/1) 
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
Age of the patient 
(years/months) 
                    
Time spent at (in) the 
dispensary (seconds) 
                    
Number of drugs 
prescribed 
                    
Number of 
antimicrobials 
prescribed 
                    
Number of 
antimicrobials 
dispensed 
                                   
 
 
     
Knowledge of dosage  1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
The dose                                    
The frequency of 
administration  
                                   
The duration of 
treatment 
                                   
The reason for 
prescription of each 
drug 
                                   
TOTAL                                    
 
Knowledge of labeling 
 
Knowledge of 
labeling  
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
Expiry date                                     
Generic name                                    
Strength                                    
Dosage                                    
Quantity of 
the drug. 
                    
TOTAL                                    
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iii. Antimicrobial availability form  for the year 2015 
Facility Name: ……………………………………  Medicine Name:…………………………..….                       
Formulation: …………………………….   Strength: ……………………………………………… 
Name of Alternative/Substitute Antimicrobial: …………………………………… Score:  (0/1) 
 MONTH  WEEK ONE WEEK TWO WEEK THREE WEEK FOUR 
1.  January         
2.  February         
3.  March         
4.  April         
5.  May         
6.  June         
7.  July         
8.  August         
9.  September         
10.  October         
11.  November         
12.  December         
 
 
Comments (indicate the stock on hand of the primary antimicrobial agent and its substitute on the 
data collection day…i.e. all the strengths, formulations, and units of the antimicrobial available): 
…………………………………………………………………………………………………………
…………………………………………………………………...………………………………………
………………………………………………………………………………………………………….. 
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iv. Facility indicator consolidation reporting form 
 
Facility Name: ………………………………………    Date: ………………………  
 
 
 This facility National standard 
 
Number of cases Prescribing    
Patient care   
Average number of medicines prescribed % % 
Percentage of medicines prescribed by generic name % % 
Percentage with encounters with antimicrobials prescribed % % 
Percentage with encounters with injection antimicrobials prescribed % % 
Percentage of medicines prescribed on the essential drugs list % % 
Average consultation time Minutes Minutes 
Average dispensing time Seconds  Seconds  
Percentage of medicines actually dispensed % % 
Percentage of medicines adequately labeled % % 
Percentage correct patient knowledge of dosage % % 
Availability of essential medicines list or formulary Yes/No Yes/No 
Percentage availability of first line key indicator medicines % % 
Percentage availability of second line key indicator medicines % % 
 
Comments:………………………………………………………………………………………………
…………………………………………………………………………………………………………
…………………………………………………………………………………………………………
…………………………………………………………………………………………………………. 
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v. Facility medicines use indicator consolidation form 
 
Seq Facility Av. # 
of  
Drugs 
Rx 
%  
Gen. 
% 
AMC 
%  
Inj. 
AMC 
% on 
EML 
Av. 
Cons. 
Time 
Av. 
Disp. 
time 
% of 
AMC 
Disp 
% 
label 
% 
adeq 
Kno 
EML  
(Y/N) 
% of 1
st
 
line 
AMCs 
In stock 
% of  2
nd
 
line 
AMCs 
In stock 
1.                
2.                
3.                
4.                
5.                
6.                
7.                
8.                
9.                
10.                
11.                
12.                
13.                
14.                
15.                
16.                
17.                
18.                
19.                
20.                
Mean               
Maximum              
Minimum              
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Appendix 2: Calculation formulae for the rational medicines use indicators 
 
1. Prescribing indicators (C) 
 
The calculations needed to summarize the indicators for each facility were either made directly on the 
form, or the data was entered on a computer worksheet. 
The date of treatment can be useful to verify that cases were distributed evenly throughout the review 
period. Age was analyzed by counting the number of cases in each age group (under 12 years and 12 
years and older) which provides a check that patients were collected from both groups. 
i. Percentage of medicines prescribed by generic name Formula: Percentage of medicines 
prescribed by generic name (E) = (D/B) x 100% 
The national EDL was used as a reference list to measure generic name usage.  
ii. Percentage of encounters with an antibiotic prescribed (G): divide the total number of patients 
prescribed with one or more antimicrobials (F) by the total number of encounters and 
multiplied by 100 to make a percentage (A). 
Formula: Percentage of encounters with an antibiotic prescribed (G) = (F/A) x 100% 
iii. Percentage of encounters with an injection prescribed (I): divide the total number of patients 
prescribed with one or more injections (H) by the total number of encounters (A), and 
multiply by 100 to make a percentage (I) 
Formula: Percentage of encounters with an injection prescribed (I) = (H/A) x 100% 
iv. Percentage of medicines present on the essential medicines list (EML) or formulary (K): this 
was calculated by dividing the total number of EML medicines prescribed (J) by the total 
number of medicines prescribed (B) and the answer multiplied by 100 to express as a 
percentage (K). 
Formula:  
% drugs present on the essential medicines list (EML) or formulary (K) = (J/B) x 100% 
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2. Patient care (pharmacy/dispensing) indicators 
 
i. Percentage of medicines actually dispensing (U): The total number, as B on the previous 
form, will be calculated again because the group of patients is different. All the medicines 
prescribed for this group will be B1. All drugs prescribed (B1) and actually dispensed (T) are 
added. Divide the total of medicines dispensed by the total of medicines prescribed and 
multiply by 100 to express as a percentage (U). 
Formula: Percentage of medicines actually dispensing (U) = (T/B1) x 100% 
 
ii. Percentage of medicines adequately labeled (W): the total number of medicines with adequate 
labels for each patient (V) is calculated and divided by the total of medicines dispensed (T) 
and multiplied by 100 to express as a percentage. 
 
Labeling score: was calculated by considering five essential dispensing quality attributes: expiry 
date, generic name, strength, dosage and quantity of the drug. Correct labeling will be given a score 
of 1 per attribute and incorrect or no labeling was scored 0, and the total dispensing score for each 
medicines was calculated (maximum total score of 5 per medicine dispensed). A score of 2.70 and 
above is regarded as a satisfactory quality of labeling, representing 54% of the total score (Boonstra 
et al, 2003). 
Formula: Percentage of medicines adequately labeled (W) = (V/T) x 100% 
 
iii. Percentage knowledge of dosage (Z): the total number of patients who can correctly report the 
dosage of all drugs (Y) is divided by the number of people questioned (X) multiplied by 100 
to express as a percentage (Z). 
Adequate knowledge of dosage were limited to patients’ recall of the dose (medicines quantity), the 
frequency of administration (time intervals and/or the actual times), the duration of treatment and the 
reason for prescription for each drug prescribed. A correct answer was assigned a score of one and 
incorrect answer zero. For each medicine actually prescribed, the total knowledge score was 
calculated (max. knowledge of 4 per drug) (Boonstra et al, 2003). 
Formula: Percentage knowledge of dosage (Z) = (Y/X) x 100% 
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3. Health facility indicators 
 
i. Availability of the copy of essential medicines list or formulary-this is a ‘yes’ or ‘no’, no need 
for calculations. 
Only the availability of the updated Zambia standard treatment guideline (STG), 2013, will be 
considered. The Zambia essential medicines list has been compiled in the STG. 
ii. Availability of key medicines-the column for number of key indicator medicines in stock were 
added and divided by the total number of key indicator medicines surveyed, and multiplied by 
100 to express as a percentage. 
Formula: (# of medicines in stock/ # of medicines surveyed) x 100% 
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Appendix 3: Sampling frame (Lusaka district community health centers 2014-based on the 
Zambia Central Statistical Office data-2014) 
 
SN.  FACILITY NAME  LEVEL TYPE     2014CENT
ER ROP 
6-11 
MONTH
S (2%) 
12-59 
MONTH
S (16%) 
6-59 
MONTH
S (18%) 
1 CHAWAMA LARGE SC 142,120 2842 22739 25582 
2 CHELSTONE LARGE SC 112965 2259 18074 20334 
3 CHILENJE LARGE SC 104785 2096 16766 18861 
4 CHIPATA LARGE SC 147121 2942 23539 26482 
5 KALINGALINGA LARGE SC 81637 1643 13062 14695 
6 KAMWALA LARGE SC 117978 2360 18876 21236 
7 KANYAMA LARGE SC 169435 3389 27110 30498 
8 MATERO REF LARGE SC 121074 2421 19372 21793 
9 BAULENI MEDIUM SC 84845 1697 13575 15272 
10 GEORGE MEDIUM SC 160177 3204 25628 28832 
11 KABWATA MEDIUM SC 97371 1947 15579 17527 
12 MUTENDERE MEDIUM SC 99234 1985 15877 17862 
13 NG’OMBE MEDIUM SC 50733 1015 8117 9132 
       
14 (1) AIRPORT SMALL HC 6241 125 999 1123 
15 (2) CENTRAL PRISONS SMALL HC 7597 152 1215 1367 
16 (3) CHAINDA SMALL HC 49324 986 7892 8872 
17 (4) CHAISA SMALL HC 70050 1401 11208 12609 
18 (5) CHAZANGA SMALL HC 28731 575 4597 5172 
19 (6) CIVIC CENTRE SMALL HC 40962 819 6554 7373 
20 (7) KANYAMA WEST SMALL HC 169435 33989 27.110 30498 
21 (8) KAUNDA SQUARE SMALL HC 49170 983 7867 8851 
22 (9) LILAYI SMALL HC 17604 352 2817 3169 
23 (10) MAKENI SMALL HC 46130 923 7381 8303 
24(11)  MANDEVU SMALL HC 86731 1735 13877 15612 
25 (12) MATERO MAIN SMALL HC 103995 2080 16639 18719 
26 (13) RAIL WAY SMALL HC 76253 1526 12201 13726 
27 (14) STATE HOUSE SMALL HC 23531 471 3765 4235 
28 (15) STATE LODGE SMALL HC 8505 170 1361 1531 
29 (16) St. AGNESS SMALL HC 11298 226 1808 2034 
30 (17) FREEDOM SMALL HC     
31 CHIMWEMWE HP/GEORGE SC     
32 CHRISTIAN CENTER MOBILE HC     
33 CHUNGA SC HP/ MATERO REF     
34 EVELYN HONE HP/RAILWAY HC     
35 GARDEN SC HP/ CHIPATA HC     
36 KANYAMA SH HP/ KANYAMA HC     
37 LILANDA SC HP/RAILWAY HC     
38 NIPA HP/ GEORGE     
39 TWATASHA DISTRICT      
DISTRICT TOTAL 2, 115, 596 42, 312 338, 495 380, 807 
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KEY 
1. The highlighted facilities were selected and included in the study 
2. HC: Health Center 
3. HP: Health Post 
4. SC: Sub-center 
 
NOTE:  
 The small health centers have been re-numbered in brackets for sampling purposes. Check sampling 
frame. 
 Clinic number 19 (6), Civic Centre clinic, a small health center (HC) was originally sampled but was 
not operational at the time of data collection and was therefore conveniently replaced by clinic number 
26 (13), Railway clinic, another small health center (HC). 
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Appendix 4: The Lusaka District facility map and catchment populations 
(The dotted lines are zonal boundaries. There are 8 zones in total…….counting anticlockwise from 
the top right corner. The dot “LDHMT” in Zone 6 is the geographical location of the Lusaka 
District Health Management Team (Office). The catchment populations indicated on the map have 
not been updated) 
 
Zone 1 
Zone 2 Zone 3 
Zone 5 
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Appendix 5: Key indicator antimicrobial medicines from the essential medicines list 
In order to assess the availability of antimicrobials, a short list of antimicrobial medicines, that are 
essential for the treatment of the 15 common infectious and trauma health problems in Lusaka 
District, were identified (WHO, 1993; Republic of Zambia Ministry of Health, 2011). The table 
below has been adapted from the Zambia Standard Treatment Guidelines (STG), 2013, and the World 
Health Organization, ‘How to investigate drug use in health facilities: selected drug use indicators’, 
(1993); and the Lusaka Provincial Health Bulletin (2011) which listed the most common infectious 
and trauma health problems.  
SN Health Problem Drug Name Alternative/Sub. Formulation (S) 
1.  Non–bloody diarrhea Nilazoxanide  Tablets/suspension 
2. Amoebic dysentery Metronidazole Tinidazole Tablets/suspension 
3. Bacterial dysentery Ciprofloxacin  Norfloxacin Tablets/suspension 
4.  Throat infections
 
Penicillin V  Tablets/suspension 
5.  Ear infections  Amoxicillin Ampicillin (± 
salbactam) 
Capsules/suspensions 
6. RTI-pneumonia Benzyl Penicillin inj. Ceftriaxone/Cefotaxim
e injection 
Injections 
7. Lower RTI-non pneumonia Cefuroxime Cefixime/cefpodoxime Tablets/suspension 
8. Penicillin allergy/second line  Erythromycin Azithromycin  Tablets/suspension 
9. Conjunctivitis  Tetracycline eye ointment Chloramphenicol eye 
ointment/solution 
Eye drops/ointment 
10. Sexually Transmitted 
Infections 
Doxycyclines Tetracycline Capsules/Tablets 
11. Uncomplicated malaria Artemether + 
Lumefantrine-  
Artemisinin based 
treatments 
Dispersible 
Tablets/suspension 
12. Burns Silver Sulfadiazine  Topical 
ointments/creams 
13. Intestinal worm infestations Mebendazole Albendazole Tablets/suspension 
14. Fungal skin infections Azole creams,  Salicylate, 
Whitefield’s ointment 
Topical creams, 
ointments 
15. Trauma (RTA & Domestic) Tetanus vaccine  Injection  
 
*RTI-respiratory tract infections 
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Appendix 6: Model training course for data collectors 
 
TOPIC  DAY TEACHING AIDS TIME 
1. Overview of the project 
 What an indicator study is and the Ministry of 
Health’s interest in the indicators 
 Role of the data collectors 
 Work to be carried out; start and finish dates 
 Days to work and compensation 
 Number of sites to be visited by each data collector 
 
 
 
 
 
 
 
 
 
 
Day one 
Study briefing 
package 
60 
minutes 
2. How to collect data 
 Show prescribing and patient care indicator forms; 
facility summary form, and the drug use indicator 
consolidation form 
 Indicate fields for different types of data and point out 
that some require coded data 
Data collection forms 15 
minutes 
3. Practice session to enter data into the prescribing 
indicator forms 
 10 sample cases which are problem free, and illustrate 
how to transcribe data from the health facility records to 
the forms; 
 10 additional sample cases illustrating various 
problems likely to be encountered, (illegible data, 
encounters for which no drug is prescribed, antimicrobials 
not on drug list) 
Prescribing indicator 
forms; sample data 
for entry 
60 
minutes 
4. Observing and interviewing patients 
 How to sample patients for process of care and 
knowledge 
 Getting accurate times on patient consultations and 
dispensing encounters 
 Criteria for adequate knowledge and labeling 
Patient care forms 50 
minutes 
5. Collecting other indicators 
 Criteria for Essential Medicines List and formulary 
Patient care forms, 
and drug availability 
30 
minutes 
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 Surveying health facility stores for medicines in store form 
6. Field practice 
 Visit and collect complete set of data from 1 facilities 
 Complete facility summary table and report 
Day two All forms 1 day 
7. Final discussion 
 Review experiences of field test and address concerns 
and questions 
 Review the appropriateness of the data collection 
forms and procedures, and make relevant corrections 
 Assign data collectors to working teams 
 Finalize data collection plan and organization of work 
(schedules, transport, communication) 
Day three Schedules  Half (½) 
day 
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Appendix 7: Participation information sheet. 
         
UNIVERSITY OF THE WESTERN CAPE 
Private Bag X 17, Bellville 7535, South Africa 
Tel: +27 (0) 21 959 2809/2166, Fax: +27 (0) 21 9592872 
Email:  soph-comm@uwc.ac.za 
Website:  http://www.uwc.ac.za/faculties/chs/soph 
 
 
Project Title: Assessment of the rational use and availability of antimicrobials at primary level health 
facilities under the Lusaka district community health office, Zambia 
 
What is this study about? 
This is a research project being conducted by Ephraim Phiri at the University of the Western Cape.  
We are inviting you to participate in this research project because you are a patient in this facility. 
The purpose of this research project is to assess the use and availability of antimicrobials at this 
primary health facility 
 
What will I be asked to do if I agree to participate? 
You will be asked about your age (years), how many medicines were prescribed for you; whether 
antimicrobials have been prescribed for you (Y/N); number of antimicrobial medicines prescribed for 
you, the number of antimicrobials dispensed, the diagnosis and the name (s) of antimicrobials 
prescribed, whether enteral or parenteral antimicrobials were prescribed, and the appropriateness of 
labelling, and patients’ knowledge of the antimicrobial (s) dispensed. This interview will take no 
more than ten minutes. 
 
Would my participation in this study be kept confidential? 
We will do our best to keep your personal information confidential.  To help protect your 
confidentiality, having locked filing cabinets and storage areas of data collection forms, using 
identification codes only on data forms, and using password-protected computer files.  Your name 
will not be included on the data collection forms and no identification code will be used to identify 
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you. Only a non-identifying code will be placed on the data collection form, whereby only the 
researcher and the data collectors will have access to the collected data. If we write a report or article 
about this research project, your identity will not be used.   
 
What are the risks of this research? 
There may be some risks from participating in this research study. You may feel uncomfortable by 
being afraid and embarrassed to disclose personal information about the diagnosis and treatment 
prescribed. Your participation in this study may also cause fatigue. 
 
What are the benefits of this research? 
This research is not designed to help you personally, but the results may help the investigator learn 
more about the use and availability of antimicrobials in Lusaka district. We hope that, in the future, 
other people might benefit from this study through improved understanding of antimicrobial use as 
this will avert antimicrobial resistance and guarantee use of the same affordable antimicrobials in the 
future generations.  
 
Do I have to be in this research and may I stop participating at any time?   
Your participation in this research is completely voluntary.  You may choose not to take part at all.  If 
you decide to participate in this research, you may stop participating at any time.  If you decide not to 
participate in this study or if you stop participating at any time, you will not be penalized or lose for 
access and right to health; for which you otherwise qualify. 
Is any assistance available if I am negatively affected by participating in this study? 
 
Should you be negatively affected by participating in this study counselling services shall be 
provided, and where possible referral for care. 
 
What if I have questions? 
This research is being conducted by Ephraim Phiri, School of Public Health at the University of the 
Western Cape.  If you have any questions about the research study itself, please contact Ephraim 
Phiri, at: cell number: +260 979 356429 or e-mail address: phiri.ephraim@yahoo.com 
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Should you have any questions regarding this study and your rights as a research participant or if you 
wish to report any problems you have experienced related to the study, please contact:   
 
Director: 
Prof Helene Schneider; School of Public Health; University of the Western Cape; Private Bag X17 
Bellville 7535; hschneider@uwc.ac.za 
 
Dean of the Faculty of Community and Health Sciences:  
Prof Jose Frantz; University of the Western Cape; Private Bag X17; Bellville 7535; chs-
deansoffice@uwc.ac.za 
 
 
This research has been approved by the University of the Western Cape’s Senate Research 
Committee.   
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
76 
 
Appendix 8: Consent form. 
 
UNIVERSITY OF THE WESTERN CAPE 
Private Bag X 17, Bellville 7535, South Africa 
Tel: +27 (0) 21 959 2809/2166, Fax: +27 (0) 21 9592872 
Email:  soph-comm@uwc.ac.za 
Website:  http://www.uwc.ac.za/faculties/chs/soph 
 
 
Title of Research Project: Assessment of the rational use and availability of 
antimicrobials at primary level health facilities under the 
Lusaka district community health office, Zambia 
 
The study has been described to me in language that I understand. My questions about the study have 
been answered. I understand what my participation will involve and I agree to participate of my own 
choice and free will.  I understand that my identity will not be disclosed to anyone. I understand that I 
may withdraw from the study at any time without giving a reason and without fear of negative 
consequences or loss of benefits.    
Participant’s name……………………….. 
Participant’s signature……………………………….            
Date……………………… 
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Appendix 9: Approval letters from other institutions. 
 
 
 OFFICE OF THE DEAN DEPARTMENT OF RESEARCH 
DEVELOPMENT 
 
 
 
 
 
 29 January 2015  
 
To Whom It May Concern  
I hereby certify that the Senate Research Committee of the University of the Western Cape approved 
the methodology and ethics of the following research project by:  
Mr. E. Phiri (School of Public Health)  
 
Research Project: Assessment of the rational use and availability of antimicrobials at           primary 
level health facilities under the Lusaka District Community Health Office, Zambia  
 
Registration no: 14/10/42  
 
Any amendments, extension or other modifications to the protocol must be submitted to the Ethics 
Committee for approval.  
 
The Committee must be informed of any serious adverse event and/or termination of the study.  
 
Ms Patricia Josias  
Research Ethics Committee Officer  
University of the Western Cape  
 
 
 
 
